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1. Introduction 
The mucosa of the gastrointestinal tract is, in the human body, the widest surface of contact with 
the external environment. Under normal conditions its luminal content is represented by a mixture 
of combined nourishing elements and bacterial flora. A single layer of epithelial cells separates the 
external environment from that inside, characterized by the presence of cells belonging to the 
immune system strategically organized below the epithelial barrier to point out the presence of a 
continuous information interchange among the two environments. The epithelial barrier actively 
participates in the information interchange among external and internal environment. The 
organization of the local immune response is such to be able to discriminate among the signals 
coming from the presence of the normal microbial flora and those of danger represented by the 
presence of pathogens. From this it primarily follows the development of a tolerogenic immune-
response in the case of signals coming from the normal microbial flora or the development of an 
sustained inflammatory   response in the case of signals coming from pathogens   to accomplish  
their elimination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Intestinal mucosa components participating in the host-microbiota interactions. (Turner 
J.R. Nature Reviews Immunology 2009; 9, 799-809).
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1.1 Mucosal Homeostasis 
1.1.1 Intestinal Microbiota 
The human intestine constitutes one of the microbial ecosystems with great density of population 
presents in nature. The human intestinal microbiota, with a quantity that ranges  around 1013-1014 
microorganisms/ g colonic content with a biomass > 1 kg, outnumbers the microbial communities 
attached to the other surfaces of the human body and they are about 10 times higher than  the total 
number of our somatic and germinal cells. (Savage D.C., 1977). Thus, the intestinal microbiota of 
humans accounts for a number of genes 100 times higher than human genome (Bäckhed F. et al., 
2005). The greatest part of these microorganisms are found in the colon where the densities of 
population specifically reaches values of 1011-1012 microorganisms / ml of luminal content. 
Therefore, the human being can be considered a super organism made up by human and microbial 
cells, with a genetic unit constituted by  the whole genes present in the human genome and in the 
genome of the intestinal microbiota (microbioma) (Lederberg J., 2000). The composition of the 
intestinal microflora depends on the number and on the type of microorganisms with which the 
subject comes into contact from the birth and in the first years of life and on   the genetic 
background of the same subject.  The variety  of environmental interactions and the stochasticity of 
the microbial populations with which the subject comes into contact make  the microbiota of a 
single subject exclusive. In the context of a specific intestinal habitat, some microbial components 
are autochthonous or "residents", while others, so called allochthonous components, originate from 
the ingested food, from the water or from other elements present in  the external environment 
(pollutants) and this tight  interactions makes this ecosystem very dynamic. The relationship that is 
established between the host and components of the microbiota has often been described as 
commensalism (a partner draws benefit while the other doesn't result influenced), but it is surely 
more appropriated to define it as symbiotic or mutual (both the partners increase their fitness).  
The bacteria, fungi, protozoa, and viruses that inhabit the gastrointestinal tract combine to comprise 
the host’s intestinal microbiota and are integral to digestive and metabolic processes necessary for 
general health. Our knowledge of the composition of the human gut microbiota was limited to 
culture-based studies until recent initiatives utilizing high-throughput sequencing and molecular 
phylogenetic approaches based on sequencing bacterial 16S rRNA genes made available a detailed 
inventory of the normal human gut microbiota (Eckburg P.B. et al., 2005; Palmer C. et al., 2007; 
Xu J. et al., 2007; Zoetendal E.G. et al., 2002). Such comprehensive enumeration studies of 
microbial diversity within the mammalian gut not only improved our understanding of the 
population composition and the dynamics and ecology of the gut micro-biota but also provided 
evolutionary insight into the host–microbe mutualism. Although there are at least 55 divisions of 
bacteria and 13 different divisions of archaea on Earth, the human distal gut microbial community 
is dominated by members of just two bacterial divisions, Bacteroidetes and Firmicutes, and one 
  
5 
member of Archaea, Methanobrevibacter smithii (Eckburg P.B. et al., 2005). In contrast to the low 
levels of deep diversity, the microbial diversity in the mammalian gut exhibits high levels of 
variation at the level of species and strains. 
In addition, the microbiota of the human intestine is quantitative and qualitatively different in the 
various compartements of the gastrointestinal tract (Figure 2) (Tiihonen K. et al., 2010; Savage 
D.C., 1977; Berg R.D., 1996). On these differences a horizontal stratification is inserted with the 
presence of various microbial communities in the intestinal lumen, in the layer of mucus, in the 
crypts and directly adherent to the epithelial cells (Rozee K.R. et al., 1982; Lee A., 1984). 
 
 
Figure 2. Common members of the intestinal microbiota in the different compartments of the 
gastrointestinal tract. (Tiihonen K. Ageing Research Reviews. 2010; 9: 107-16). 
 
In numerical terms, esophagus and stomach show the lowest bacterial load. The normal esophageal 
microbiota is relatively simple and the preponderant cultivable bacteria are optional anaerobia that 
originates from the oral mucosa, like Streptococcus and Lactobacillus. Similarly the stomach, 
contains low levels of lactobacillus and other acid resistant microorganisms (101-102/ ml of 
content), that usually come from the oral mucosa. The microbiota load increases with the 
progression toward the ileum and colon that represents the gastrointestinal tract with the highest 
concentration of bacteria that show remarkable microbial difference [1011-1012 / ml of luminal 
content, about 60% of the fecal mass (Guarner F. and Malagelada J.R., 2003)]. While in the small 
intestine optional anaerobial bacteria are present, in the colon the microbiota is largely made up by 
anaerobes. 
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The microbiota of the infant is seeded at birth and is initially undifferentiated across the various 
body habitats. A variety of factors—including method of delivery (vaginal versus Cesarian 
section), breast feeding, and weaning— influence the infant microbiota. For example, the 
microbiota of babies delivered vaginally are dominated by Lactobacillus, Prevotella, and 
Atopobium, whereas babies delivered by Cesarian section have a microbiota that more closely 
resembles that of the maternal skin community, with staphylococci being a dominant early member 
(Ravel J. et al., 2011). The dominance of aerobic bacteria at birth is altered during peri- and 
postnatal development. The microbiota diversifies over the first few weeks of life to form a 
complex anaerobe-dominated microbial community (Mitsou E.K. et al., 2008). However, within 
the second year of life the microbiota composition becomes more stable and similar to adult gut 
microbiota, although some studies have reported that adolescents have a higher abundance of  
bifidobacteria and clostridia than adults (Agans R. et al., 2011). During old age a final set of age-
related shift in the composition and function of microbiota is observed (Qi Y. et al., 2012). 
Functions of the microbiota 
 The intestinal microbiota has been demonstated to be involved in metabolic, trophic and protective 
functions (Nicholson J.K. et al., 2005). In addition microbiota contributes to the development and 
function of:  
- Metabolic activity and trophic functions 
The most important metabolic activity of intestinal microbiota is represented by the fermentation of 
non digestible residues of the diet and/or of endogenous mucus   produced by the epithelium. The 
host's mucus, in addition to provide protection against the adhesion and the invasion  of pathogens, 
represents an important reservoir of glycans, mucin, glycosphingolipids, hyaluronic acid and 
heparin (Hooper L.V. et al., 2002) and contribute to limit the potential damages  caused from 
drastic changes in the availability of polysaccharides in the diet (Bäckhed F. et al., 2005).  
The intestinal bacteria draw the required energy through the metabolism of sugars and proteins 
(activity known with the term of fermentation). The modification of non digestible polysaccharides 
of the diet (cellulose, hemicellulose, pectin, non-digestible starch) is achieved with  bacterial 
enzymes that modifies these latter substrates in  volatile (carbonic anhydride, hydrogen, etc.) 
compounds and Short-Chain Fatty Acids (SCFA The synthesis of the fatty acids produces an 
acidification of the intestinal pH, that constitutes an efficient system of defense against pathogens 
microorganisms. The generation of SCFA, influences also the epithelial intestinal cells, facilitating 
their growth and differentiation. In fact, butyrate constitutes the principal energetic source of the 
epithelial cells of the colon (around 70% of the energetic intake). Acetate and propionate are, by 
contrast, able to regulate the glucose metabolism; their absorption induces a lower glycemic 
response after ingestion of oral glucose or a standard meal. The microorganisms of the colon also 
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develop a fundamental role in the synthesis of vitamins, as B12 and K and in the absorption of  
calcium, magnesium and iron. 
- Protective function: 
This function involves the inhibition of the pathogen flora. This is accomplished by the competition 
for the nutritional substrates and the adherence to epithelial cells (Bernet M.F. et al., 1994).  Germ-
free animal, result more sensitive to the infections  (Taguchi H. et al., 2002). 
- Functions on the development of the immune system of the host 
The microbiota has also a pivotal role in the development of the immune mucosal system, both in 
its development and function; in germ-free mice the intestinal colonization is followed by an 
enhanced number of intraepithelial lymphocytes and of   the lymphocytes infiltrating the lamina 
propria as well as  by  an increased number and  size of the lymphoid follicles that show the  
presence of germinal centers containing  immunoglobulin producing lymphocytes. The immune 
response towards the microorganisms relies on both innate and adaptive components as 
immunoglobulin secretion. The greatest part of the bacteria that are found in the human feces 
appear covered by specific IgA. The adaptive response of secretory IgA towards the intestinal 
microbiota allows the host to response to fluctuations in the bacteria concentration thus 
contributing to the mucosal homeostasis (Macpherson A.J. and Uhr T., 2004).  
 
1.1.2 The intestinal barrier 
The intestinal barrier is constituted by a single layer of epithelial cells that separates the intestinal  
lumen from the  internal environment. The intestinal epithelium includes different types of cells: 
the enterocytes that have absorptive function, the goblet cells appointed to the production of  
mucus, the Paneth cells that have the ability to produce antimicrobial peptides and enteroendocrine 
cells. Altogether the intestinal epithelium  extends to a surface of 400 m2 covering anatomical 
structures organized so that to offer the maximum surface in the smaller possible (conniving 
valves, villi, microvilli) space.  The integrity of the epithelial barrier is crucial in protecting the  
host from the microorganisms and from the alimentary antigens. The different described epithelial 
cells contribute to this function: the enterocytes migrate from the bottom of the crypts to constitute 
the epithelium of surface endowed with tight junctions constituted by trans-membrane proteins , 
claudin and occludin linked by non covalent bonds. Such junctions develop a sealing function 
forming around the cellular perimeter a continuous belt called zonula that limits the passage of 
water-soluble molecules; moreover they contribute to the maintenance of the polarity of the 
epithelial cells. The muciparous cells strengthen the epithelial barrier thanks to the production of  
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mucus that covers the whole intestinal surface. The mucins are the principals component of the 
mucus that  covers the epithelial surface of the gastrointestinal  tract. The mucins is a glycoprotein 
whose glucidic part, being highly absorbent, attracts a lot of water increasing the stringiness. The 
mucus is organized in a double layer with a denser layer to contact with the epithelial cells and one, 
less dense, directed toward the intestinal  lumen. The microorganisms of the intestinal flora 
primarily occupy this layer reaching only in small measure the deep layer. 
The Paneth cells of the small intestine and cells with analogous function   in the colon  are located 
on the bottom of the crypts and, due to their ability to produce antimicrobial pepetides, they limit 
the concentration of the bacteria penetrated in the deep layer of the  mucus. 
The integrity of the epithelial barrier and the intestinal homeostasis depends in great part on the 
continuous information interchange between the microbiota and the cells of the innate immunity 
with the contribution of the epithelial cells. To this purpose myeloid cells (dendritic cells, 
macrophage) as well as epithelial cells express surface receptors (Toll like receptor) and 
intracellular receptors (NOD - Nucleotide-binding-oligomerization domain) able to distinguish 
molecular specific determinants, conserved over  the evolution, of  microbial (PAMPs) origin. The 
microbiota / epithelial cells interaction triggers a physiological state of cellular activation with 
production of cytokine and chemokine and anti-apoptotic factors that stimulate the survival of the 
epithelial cells, their proliferation and the rapid reconstitution of the epithelial layer after the 
damage. The same receptors are also implicated in the production of antimicrobial peptides by the 
Paneth cells. 
 
1.1.3 GALT 
The lymphoid tissue   associated to the intestine (Gut Associated Lymphoid Tissue, GALT), 
represents the wider lymphoid tissue of the whole organism, considered the enormous surface of 
the intestinal mucosa to which is in partnership (Figure 1). The lymphoid cells are either organized 
in follicles (Peyer’s patches in the  small intestine, lymphoid follicles in the colon) or dispersed in 
the  lamina propria and in the layer of epithelial cells. The lymphoid structures (Peyer’s patches, 
colon’s lymphoid follicles) together with the mesenteric lymph nodes represent the sites of 
induction of the immune response. The dendritic cells once captured the antigens at the mucosa 
surface migrate into   these sites in order to present the antigens to T lymphocytes. The T 
lymphocytes, once primed by the dendritic cells acquire the role of effectors of the immune 
response with different function (lymphocytes CD4+Th -1, lymphocytes CD4+Th -2, lymphocytes 
CD4+Th -17, lymphocytes regulators). They  then migrate in the circulatory stream after the 
acquisition, on the surface, of the expression of integrins (α4β7, αEβ7) that allow their recognition 
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by the lymphoid intestinal tissue where, they migrate back to  perform  their effector functions in 
the lamina propria (lymphocytes  α4β7+) and in the epithelium (lymphocytes αEβ7+). 
Dendritic cells: 
Dendritic cells migrate from the tissues to the secondary lymphoid organs in order to present  the 
antigen to the T cells. Although at the beginning they were considered as activators of the immune 
system in response to external stimuli (infectious agents), recently they have been recognized to 
play a fundamental role in the induction and maintenance of host tolerance. Tolerance represents 
the establishment of an immune-mediate process that prevents the inflammatory response toward 
endogenous antigens, harmless food-derived antigens or antigens associated to the microflora. The 
circulating precursors of the dendritic cells are distributed in the peripheral tissue and in the 
lymphoid organs, where they differentiate in two types of dendritic cells characterized by different 
functions: the plasmacytoid dendritic cells and the conventional dendritic cells. Dendritic cells are 
in two functionally different conditions: naïve and mature dendritic cells. Naive dendritic cells are 
present in the peripheral tissue where they have mainly phagocytic functions, whereas  mature 
dendritic cells are found in the lymphoid organs and they are specialized in the antigen presentation 
and characterized by the expression of surface of costimulatory molecules that are mandatory for 
the activation of the T cells. Mature dendritic cells derive from the naive ones after a process of 
maturation triggered by inflammatory stimuli and that promotes the migration of the dendritic cells 
in the lymph nodes. Under homeostatic condition, nevertheless, there is a low but constant 
migration of naive dendritic/semimature cells from the peripheral tissue to the draining lymph 
nodes. These cells are probably involved in the induction of the tolerance to self-antigens . 
Dendritic cells isolated from the intestinal tissue are endowed with particular functional features 
including the ability to induce peripheral regulatory Foxp3+cells, the differentiation of Th-17 cells 
and the Ig-A switch in the B cells. These functions are associated to different types of dendritic 
cells that are distinguishable for the presence of different surface antigens. At  least three different 
functionally types of dendritic cells have been described. CD103+ dendritic cells expressing high-
level of CD11c+ able to promote, under the influence of retinoic acid and TGF -β the development 
of regulatory cells  to limit the inflammatory response  response  toward the microbial antigens. 
Dendritic cells expressing high-level of CD11b+  and TLR5 able to induce the differentiation of Th-
17 cells and a third type characterized by the expression of the CD70 and CX3CR1 able to 
response  to the ATP of bacterial origin inducing the differentiation of  Th-17 cells. Dendritic cells 
able to induce Th-17 seem to be e also able to favor the IgA switch in the B cells. Since the 
intestinal dendritic cells probably derive from the circulating monocytes migrated inside the tissue, 
the different functions of the dendritic cells strictly derive from the interaction with the 
microenvironment. Different cellular types contribute directly or indirectly to the mucosal 
conditioning of the dendritic cells: the epithelial cells through the production of TSLP able to 
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inhibit the synthesis of IL-12 and the production of TGF-β and retinoic acid able to direct the 
dendritic cell toward the induction of regulatory cells. Stromal cells through the production of 
TGF-β that inhibit   the production of cytokine inflammatory by  resident macrophages. These 
conditioned macrophages limit the ability of the dendritic cells to induce Th -17 cells.  
 
T lymphocytes: 
The CD4+ T lymphocytes are classically classified  in T helper (Th-1, Th-2, Th -17) and T 
regulatory cells. The Th-1 lymphocytes are inflammatory lymphocytes that releases IFN-γ and are 
involved in the immunity against the pathogenic intracellular agents, while the Th-2 lymphocytes 
are  mainly involved in the B cells response  providing growth factors as IL -4. The Th-17 
lymphocytes produce a range of cytokine as IL-17A, IL-17F, IL-21, IL-22, IL-26 involved in the 
activation of the neutrophils and in the immune response  against  extracellular bacteria and fungi. 
Under pathological conditions, as in  inflammatory bowel disease, autoimmune diseases or in the 
allergies, T lymphocytes are responsible for  the maintenance of the chronic inflammation and for 
its polarization. For example, inflammatory bowel disease,  are associated with Th-1 polarization in 
the case of  Crohn’s disease and to Th-2 polarization in the case of ulcerative colitis. The Th-17 
response , that is present in both pathologies, seems to have a protective role, but under 
pathological conditions as in the case of autoimmune diseases, seems instead to develop a key role 
in the occurence of chronic inflammation. The T regulatory lymphocytes   suppress the function of 
the T effector cells and they are therefore essential to counteract  the inflammatory responses  (Zhu 
J. and  Paul W.E., 2010).  
• T helper cells 
T helper cells  1 (Th1) are characterized by the production of interferon -γ (IFN -γ) sustained by IL-
12 and IL-23 produced by the denditric cells and they are important for immune responses  towards 
intracellular pathogens (virus and bacteria). The fundamental transcription factors required for the 
Th-1 differentiation and production of cytokine are T-bet and STAT. Particularly IFN - γ induces 
the activation of STAT1, IL-12 induces the activation of STAT4 and these two transcription factors  
upregulate  T-bet, that plays a fundamental role in the Th -1 differentiation. T-bet is a negative 
regulator of GATA-3, fundamental transcription factor in the Th2 differentiation. IFN-γ stimulates 
the anti microbial activity of the phagocytes favoring the clearance of the phagocytosed 
microorganisms; in addition it stimulates the production of IgG able to opsonise  the bacteria and to 
activate the complement; these two  mechanisms favor the phagocytosis and subsequent clearance 
of bacteria. IL-2 produced by the same Th1 acts as autocrine growth factor and together with the 
IFN-γ stimulates the proliferation and differentiation of the cytotoxic CD8+ T lymphocytes that kill 
the infected cells. Finally IFN-γ amplifies the differentiation of the CD4 T cells in Th1 inducing the 
  
11
activation of the macrophages with production of IL-12. T helper 2 cells (Th2) are characterized by 
the production of IL-4, IL-5, IL-13 and IL-25 and they play a critical role against the helminth 
infections and allergic reactions. The TH-2 differentiation of T lymphocytes depends on the 
presence of IL-4 that activates STAT 6, a transcription factor that induces the expression of GATA-
3, a transcription factor distinctive of  Th2 cells. GATA -3 inhibits the intracellular signaling  of 
STAT4, that  is required for Th1 differentiation. The principal Th2 effector functions are 
represented  by activation and expansion of eosinophils and mast cells and IgE production. Such 
functions are mediated  by IL-4, IL-5 and IL -13 production.  
From above, it  is appreciable that the functional polarization of  T cells is not only influenced by 
the type of antigen and its concentration, but also by the presence of particular co-stimulation 
signals, by  the prevailing cytokines in the environment and by the transcription factors that, 
through a positive or negative feedback activate and inhibit a specific lineage  program. In this 
context it is useful to underline that recent studies have shown that IL-25, a family member of the 
IL-17,  produced by T cells , but also by mast cells, alveolar macrophages, eosinophils, and 
basophils, pulmonary epithelial cells and intestinal epithelial cells, starts, promotes and expands the 
Th-2  mediate response  favoring the establishment of some allergic diseases (Caruso R. et al., 
2011) and it inhibits the Th-17 response  in animal models of autoimmune diseases as multiple 
sclerosis and diabetes.  
The T 17 helper cells  (Th-17)  have been recently described as lineage with  independent 
differentiation. They  are involved in  the infections by  extracellular bacteria and fungi through the 
production of IL-17A, IL-17F and IL -22. They differentiate in presence of TGF -β and IL-6, which 
activate  STAT3, that positively regulate the transcription factor  RORγt, a fundamental factor for 
Th-17 differentiation. IL-23 represents, together with IL-21, an important factor for their survival 
and for their expansion. A peculiar aspect of the Th-17 cells is their plasticity. In literature there are 
evidences about the possibility that, in addition to their differentiation from naive cells as a 
consequence of the above described stimuli, they can derive from regulatory Foxp3+  T cells in the 
presence of high-level of IL-6. This inflammatory cytokine   would inhibit the expression of Foxp3 
favoring the expression of RORγt. Recent data point out that also IL-1 could favor this passage. 
Finally, Th-17 cells, in presence of high-level of IL-23 and reduced levels of TGF-β can express 
IFN-γ maintaining the expression of IL-17 that can be later on definitely lost. These Th-17 derived 
IFN-γ cells producing cells are called simil Th -1. The final step of conversion (IFN-γ+ IL-17-) is 
inhibited by CD4+CD25+Foxp3+ regulatory cells  favoring  the expansion of IL-17+IFN-γ+ T cells  
(Abdulahad W.H. et al., 2011;. Morrison P.J.  et al., 2011).  
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• Regulatory cells  
Regulatory cells are able to inhibit the response and the proliferation of the effector T cells. Two 
subpopulations of cells can be identified: natural CD4+ CD25+ (nTreg) regulatory T cells and 
peripheral regulatory T cells. The natural regulatory cells are originated in the thymus  and 
constitutively express on their cellular membrane the CD25 (chain of the receptor of the IL-2 (IL-
2R)), the CTLA-4 (cytotoxic T lymphocyte-associated antigen 4) and the GITR (glucocorticoid-
induced TNF receptor family-related gene). A intracellular marker that is essential for the 
development and the function of regulatory cells is the transcription factor Foxp3 (X-linked, 
forkhead / winged helix transcription factor) (Hori S. and Sakaguchi S., 2004). Absence of  Foxp3 
is associated to a morbid condition linked  to the chromosome X, called "IPEX", characterized by 
immune dysregulation, polyendocrinopathies, enteropathies. Foxp3 represses the promoters of the 
genes involved the inflammation (Izcue A. and Powrie F., 2007). 
Peripheral regulatory cells are classically divided into 3 groups: inducible Foxp3+  cells (iTreg), 
regulatory T cells (Tr1) and the Th3 cells. To these 3 groups, a fourth group of cells has  recently 
been added: the cells that express on their surface the TGF -β linked to its latency peptide  called 
Latency-associated-Peptide (LAP+) T cells. The difference among the different groups of  
regulatory cells relies on the expression of Foxp3 that seems to characterize the iTregs alone and on 
their  prevalent mechanism of suppression: cytokine-mediated, respectively IL-10 and TGF-β 
mediated for  the Tr1 and Th-3 cells, contact-mediated for the  iTreg and probably for the LAP+ 
cells. Other  studies have however shown that the production of IL-10 and TGF-β is essential for 
the suppressive function of the Foxp3+ cells and that the expression of  cell surface LAP seem to 
characterize also the activated Foxp3 cells. At present  the classification of regulatory T cells into 
inducible Foxp3+ cells (iTreg) and Foxp3- (Tr1, Th-3) seems to be the most appropriate. Inasmuch 
it is becoming more and more evident that Foxp3-LAP+ cell population  can represent a separate 
group of regulatory cells, nevertheless its relationship with the Tr1 and Th-3 cells it is still object of 
study. 
The number and/or function alterations of the various types of regulatory cells are involved in 
several chronic diseases, such as autoimmune diseases, chronic inflammatory bowel diseases and 
allergies. 
One of the major issues being debated is the pleiotropic nature of TGF-β. On the one hand, it 
regulates the homeostasis of nTregs and perpetrates the suppression of the effector cells (inhibiting 
Th1 and Th2), and, on the other hand, as previously pointed out, it succeeds, together with IL-6, in 
inducing the Th-17 differentiation. A few studies have shown that murine CD4 (+) CD25 (+) T cells 
stimulated in vitro with antiCD3/antiCD28 antibodies may perform their suppressing action on the 
effector cells using TGF-β as effector mechanism; TGF-β is not in its secreted form but in the form 
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of a factor linked to the cell membrane and succeeds in mediating an interaction with the receptors 
present in the target cells. TGF-β is synthesized in the form of precursor that is cleaved 
intracellularly by endopeptidase. The proteolysis yields two products that assemble into a dimer. 
One is latency-associated peptide (LAP), and the other is mature TGF-β. The presence of LAP 
facilitates the transit to the cellular surface and keeps TGF-β biologically inactive and prevents 
interactions of TGF-β with receptors. The LAP-associated mature TGF-β  is referred to as “latent 
TGF-β”; it is secreted as precursor and converted in the biologically active form in the extracellular 
space through the removal of LAP. The mechanisms that lead to the removal of LAP are not fully 
known, even though it is assumed that the thrombospondin present on the macrophages should be 
able to affect the LAP-TGF-β complex (Khalil N., 1999), releasing the active form of cytokine.  
 
Host/microbiota recognition and interaction 
The various host/microbiota interactions described above occur through the recognition of 
bacterial/viral/fungal molecules by specific receptors arranged on both the cellular surface and 
inside the cytoplasm. 
 
1.1.4 Toll-like receptors 
Toll-like receptors are a family of pattern recognition receptors (PRR) that have not changed in the 
course of evolution. These receptors are expressed by various cells involved in the innate responses 
to pathogens, recognizing a few molecular profiles expressed by the pathogen-associated molecular 
patterns (PAMPs) (Medzhitov R. and Janeway C.A. Jr., 1997). As a matter of fact, even non-
pathogenic bacteria, such as those of the intestinal microflora, use the same structures for their 
recognition by the epithelial cells and by the cells of the innate and acquired immunity of the host.  
TLRs have the type I structure of transmembrane proteins with multiple extracellular cysteine and 
leucine-rich repeats (LRRs) and exhibit a single Toll/interleukin-1 (IL-1) receptor (TIR) 
intracellular domain which is similar to the intracellular receptor domain of the IL -1 family.  
There are 13 TLRs in human and mice that share a similar structure and an ancestral gene. An 
important characteristic of the signaling system is that TLR1, TLR2, TLR4, TLR5, and TLR6 are 
expressed on the cell surface and a set of TLRs sensitive to nucleic acids -TLR3, TLR7, TLR8 and 
TLR9 - are intracellular (Figure 3). 
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Figure 3. TLRs localization. (Kaufmann S.H., Nature Reviews Microbiology 2007; 5: 491-504)  
 
The lipopeptides and the other components of the Gram-positive bacteria cells activate TLR2 
together with TLR1 or TLR6; LPS activates TLR4, flagellin activates TLR5, Poly I: C (a double-
stranded RNA (dsRNA) activates TLR3; unmethylated DNA and CpG oligodeoxynucleotides (or 
CpG ODN)) activate TLR9, while single-stranded RNA and a few drugs activate TLR7.  
 
The ligands for TLR8 and TLR10 (present only in humans) and for TLR11-13 (present only in 
mice) are not known (Figure 4). 
 
 
Figure 4. TLR ligands and interactions with receptors. (Moresco E.M., Current Biology 2011; 21: 
R488-93). 
 
The TLRs are expressed by macrophages and neutrophils, as well as by dendritic cells and 
specialized phagocytes that are to stimulate the immune responses by activating the T-lymphocytes. 
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Many “non-immune” cell types, including epithelial cells, neurons, astrocytes, and fibroblasts, also 
express TLRs and respond to their activation. 
TLR signaling depends critically on four adaptor proteins (Figure 5): 
• MyD88 (Myeloid differentiation primary response gene (88)); 
• TIRAP (also called MAL);  
• TICAM1 (also called TRIF);  
• TICAM2 (also called TRAM) that directly bind to activated TLRs. 
There are two signaling pathways: the MyD88-dependent and the TRIF-dependent pathways. 
All TLRs (except TLR3), utilize a MyD88-dependent pathway after the dimerization of the TLR 
receptor. As far as the signal transmitted by TLR4 is concerned, a MyD88-dependent transmission 
pathway is known to activate the cytokine production and a MyD88-independent pathway is known 
to activate the type I interferon system. 
Once activeted, MyD88 recruits IRAK 4, IRAK1 and IRAK2. IRAK kinases then phosphorylate 
and activate the protein TRAF6, which in turn polyubiquinates the protein TAK1 in order to 
facilitate binding to IKKβ. On binding, TAK1 phosphorylates IKKβ, which then phosphorylates Iκβ 
causing its degradation and allowing NF-κB to diffuse into the cell nucleus and activate 
transcription. TAK1 may also trigger MAP (mitogen-activated protein) kinases with activation of 
AP1 and CREB (cyclic AMP response element-binding protein) (Kawai T. and Akira S., 2010). 
Signal transduction from TLRs induces the expression of numerous genes required for the 
inflammatory response, including inflammatory cytokines (TNF-α, IL-1, IL-6, IL-8, IL-12 and IL-
18), chemokines, antimicrobial molecules (such as hydrolytic enzymes, peptides, proteases), and 
costimulatory molecules important for adaptive immune activation.  
The TLR3 transmission pathway involves the recruitment of the TRIF adaptor protein and TRIF 
activates the TBK1 and RIP1 kinases; TRIF/TBK1 signaling phosphorylates IRF3 allowing its 
translation into the cell nucleus and the production of interferons type I (IFN-β). The activation of 
TLR7 and TLR9 activates a MyD88-dependent signal transmission that may also activate the IRF7 
(interferon regulatory factor 7) transcription factor with the activation of interferons type I (IFN-α) 
that are powerful anti-viral cytokines. 
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Figure 5. Signaling TLRs. (Hennessy E.J., Nature Reviews Drug Discovery 2010; 9: 293-307) 
 
 
TLR2 recognizes peptidoglycan (PGN), the component of the bacterial cell-wall of several Gram-
positive pathogenic and commensal bacterial strains. 
Studies of TLR2-deficient mice or cells derived from these animals have shown that TLR2 is 
necessary for the response to PGN, the mycoplasma lipopeptide that activates the macrophage-
activating lipopeptide-2 (MALP-2) (Takeuchi O. et al., 1999, 2000, 2001), as well as for the 
response to Lipoarabinomannan, a glycolipid associated with Mycobacterium tuberculosis (Jones 
B.V. et al., 2001). Besides, even the recognition of the lipoteichoic acids (lipidic components of the 
cytoplasmic membrane associated with the teichoic acids of the Gram-positive wall) and Listeria 
monocytogenes (a Gram-positive organism) would seem to involve TLR2. 
According to a few studies, the capacity of TLR2 to bind such a variety of ligands is founded on its 
ability to form heterodimers with other TLRs, above all TLR6 and TLR1 (Ozinsky A. et al., 2000; 
Takeuchi O. et al., 2001). 
The TLR4 receptor distinguishes both bacterial PAMPs and viral PAMPs. However, the best 
represented PAMP is LPS, an important element of the external membrane of Gram-negative 
bacteria.  
The LPS-TLR4 bond is mediated by CD14 and MD-2 proteins strengthened by LBP (LPS-Binding 
Protein), a soluble protein present in the plasma. LPS induces several immunostimulant responses, 
including the production of proinflammatory cytokines as IL-12 and inflammatory chemokines.  
Following the interaction with bacteria and/or viruses, antigen-presenting cells (APCs), 
macrophagic cells and dendritic cells, which express TLRs on their surface, bind PAMPs and begin 
a signaling series that stimulates the host’s defenses through the induction of ROS (Reactive 
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Oxygen Species) and nitrogen. 
Later, the activation of these cells leads to the production of proinflammatory cytokines that, in turn, 
upregulate costimulatory molecules, stimulating the maturation of dendritic cells and their migration 
in the lymph-nodes. 
The cell migration in both mice and humans is mediated by the chemokine receptors expressed by 
the dendritic cells following  the stimulation of TLRs (Rescigno M. et al., 1999; Sallusto F. et al., 
1999). 
The dendritic cells, getting to the secondary lymphoid organs, stimulate the T cells through the 
presentation of peptides associated with MHC molecules, linked with a secondary signal transmitted 
by costimulatory molecules as CD80/86.  
MHC are proteins codified by a multiplicity of genes called major histocompatibility complex. They 
are entrusted with the task of binding the peptidic fragments produced by the degradation of foreign 
protein antigens inside the target cell and transporting them to the surface. Hence, the T response, 
mediated by the Th-1 or Th-2 polarization, is induced at the lymph node level. 
Based on the foregoing, it seems reasonable to conclude by saying that TLRs are indispensable not 
only in the initial infection phase, when they contribute to the innate immune response, but also in 
the passage from innate immunity to adaptive response, when they condition the response of the 
dendritic cells responsible for educating T cells to the antigenic recognition and for the response 
guidance (Werling D. and Jungi T.W., 2003). 
 
1.1.5 NOD2 
 
NOD2 (nucleotide-binding oligomerization domain-containing protein 2) belongs to the NLR 
(NOD-like receptors) family of pathogens/microbe-associated molecular patterns (Strober W. et al., 
2006; Inohara N. et al., 2005). 
The NOD2/CARD15 gene (Figure 6), found on chromosome 16 in the pericentromeric region 16q, is 
the most important gene involved in the susceptibility to Crohn’s disease (CD). 
NOD2 encodes a protein of 1,040 amino acids that is expressed in macrophages, monocytes, 
dendritic cells, epithelial intestine cells and in the Paneth cells located in the terminal ileum. 
The protein comprises 2 N-terminal CARD domains, a central oligomerization domain (NOD), and 
a C-terminal stretch of leucine-rich repeats (LRRs). The CARD (Caspase Activation Recruitment 
Domain) domains are responsible for the bond with other proteins with similar domains. 
The NOD (Nucleotide Oligomerization Domain) mediates the oligomerization of the proteins 
comprising the CARD domains, allowing the activation of the NF-kB transcription factor. 
Just like the LRR (Leucine-Rich-Repeat) of the toll-like receptors, the LRR domain mediates the 
response to the muramyl dipeptide component (MDP) of peptidoglycan (PGN) of Gram-positive 
and Gram-negative bacteria. The NOD2 protein acts as an intracellular sensor in the innate immune 
response to Gram-negative and Gram-positive bacteria. 
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Figure 6. NOD2/CARD15 gene structure. 
 
The MDP stimulation activates NOD2 through an initial conformational change in the structure, 
followed by oligomerization and exposure to the CARD domain (Figure 7). In its turn, the latter 
binds to a downstream adapter molecule known as RICK (or RIP2) through a CARD-CARD 
interaction. The final result is the activation of MAP-kinase (mitogen-activated protein kinase) and 
NF-kB (nuclear factor-kB) that lead to the synthesis of various proinflammatory cytokines and/or 
chemokines (Strober W. et al., 2006).  
 
 
Figure 7. NOD2 interactions. (Strober W. Mucosal Immunol. 2011; 4: 484-495)  
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The MDP-induced NOD2 signaling acts also through a RICK-independent mechanism. NOD2 
responds in vitro to viral ssRNA or in vivo to viral infection (such as respiratory syncytial virus) 
with IRF3 activation (Sabbah A. et al., 2009). This response involves the binding of ssRNA to 
NOD2, followed by translocation of NOD2 to the mitochondria and interaction with MAVS 
(mitochondria anti-virus signaling protein), a mitochondrial adaptor molecule. Finally, the MAVS 
leads to activation of downstream signaling molecules that lead, in their turn, to the production of 
interferon-β and NF-κB activation. Overall, this NOD2 activation pathway is substantially  different 
from the MDP-induced pathway in that it involves a different ligand and a distinct downstream 
signaling pathway.  
Studies conducted on mice and humans have shown that the NOD2 stimulation of MDP in cells 
translates into variable responses that, in most cases, are lower than the responses obtained with 
TLRs stimulation (Watanabe T. et al., 2004). Although NOD2 stimulation itself results in weak 
responses, such stimulation has a considerable capacity to increase TLR responses. Such increase 
may result from the fact that TLR stimulation upregulates NOD2 expression, and combined 
stimulation of cells through upregulated NOD2 and a TLR has a synergistic effect similar to that 
seen for other combinations of TLR stimulants (Fritz J.H. et al., 2005; Hirata N. et al., 2008).  
NOD2 responses can complement or enhance innate immune response mediated by TLRs or other 
innate response elements and this occurs by virtue of its position as an intracellular response factor 
that, therefore, is involved in the neutralization of pathogens or in response to intracytoplasmic 
danger signals. NOD2 responses can conceivably provide host defense function in areas of the body 
where TLR expression is reduced because TLR function has been downregulated by constant 
exposure to TLR ligands. In fact, a tolerance-oriented down-modulation mechanism is activated in 
these areas. This is what happens in the gastrointestinal (GI) tract where the commensal microflora 
provide a source of TLR ligands that render gut epithelial cells or antigen-presenting cells tolerant to 
TLR ligands (Strober W. et al., 2006). Another mechanism by which NOD2 contributes to host 
defense is by binding to the inflammasome protein NLRP1; the complex binds pro-caspase I 
through the CARD domains of NOD2 and/or the NLRP1, leading to the activation of caspase I, 
which then acts on pro-IL-1β or pro-IL-18 to form mature forms of these cytokines that can then be 
secreted (Hsu L.C. et al., 2008).  
A new NOD2 functional activity is represented by its implication in autophagy.  
Autophagy is a complex intracellular protein degradation mechanism by which the cell forms 
double-membrane vacuoles (autophagosome) that ultimately fuse with lysosomes to eliminate 
proteins arising from cellular stress responses (Mizushima N. et al., 2008). This mechanism also 
involves the breakdown of ingested pathogenic bacteria providing antigens for antigen presentation 
in the immune response useful for host defense.  
Studies have shown that the NOD2 protein binds to an autophagic protein, ATG16L1, and co-
localizes with NOD2 at the plasma membrane level, thus facilitating the formation of an 
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autophagosome around the invading bacteria (Travassos L.H. et al., 2010).  
NOD2 has an unequivocal function as a host defense factor not only in relation to bacteria which 
express peptidoglycan, and thus MDP, but also in relation to viruses and parasites. 
NOD2 intervenes in the intestine in defense of the host through the involvement of specialized gut 
cells in the intestinal crypts called Paneth cells, which produce considerable amounts of α-defensins, 
which are NOD2-dependent anti-bacterial peptides. 
Finally, the NOD2 prominence also derives from the fact that polymorphisms in the LRR region of 
CARD15 are genetic risk factors for the occurrence of such diseases as Crohn's disease, graft vs. 
host diseases (GvHD), and allogeneic bone marrow transplantation. In addition, the mutations in the 
NOD region of CARD15 are causative of Blau’s syndrome, a granulomatous inflammation affecting 
the eyes, skin, and joints. 
 
 
1.2 INFLAMMATORY BOWEL DISEASES (IBD) 
 
The inflammatory bowel diseases (IBD) comprise Crohn's disease (CD) and ulcerative colitis (UC) 
(Baumgart D.C. and Sandborn W.J., 2007). 
Ulcerative colitis is characterized by inflammation that is restricted to the colon: it starts in the 
rectum and extends proximally in a continuous manner and often affects the periappendiceal region. 
On the other hand, Crohn’s disease affects any part of the gastrointestinal tract - mostly the terminal 
ileum - in a non-continuous manner and, unlike ulcerative colitis; it is generally associated with 
complications as stenoses, abscesses and fistulae. From a histological point of view, ulcerative 
colitis features an inflammation that affects for the most part the superficial layers of the mucosa 
(epithelium and lamina propria) with presence of epithelial damage and formation of cryptic 
abscesses. Crohn’s disease is instead characterized by a transmural inflammation affecting all the 
layers of the mucosa up to the serosa, with presence in about 15% of all cases of non-caseificant 
granulomas. In North America, the IBDs have an incidence of 2.2 to 14.3 cases per 100,000 
individuals per year with respect to UC and 3.1 to 14.6 cases individuals per year with respect to 
CD, while in Europe they have an incidence of 8.7 to 11.8 cases per 100,000 individuals per year 
(UC) and 3.9 to 7.0 cases per 100,000 individuals per year (CD), respectively. UC is more frequent 
than CD, regardless of the geographic area being considered, with an estimated number of 780,000 
individuals affected by UC and 630,000 which suffer from CD in the United States (Loftus E.V. Jr., 
2004). 
The geographic variability observed in the incidence, side by side with economic growth and the 
increase in the per capita income, together with the prevalence rate change observed in a few ethnic 
groups after their migration to other geographic areas, represent a further support to the theory that 
environmental factors and lifestyles play a role in the onset of the disease (Loftus E.V. Jr., 2004). 
The most creditable pathogenic hypothesis assumes that the onset of these diseases, in genetically 
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predisposed individuals, is based on an altered immune response to one’s bacterial flora. In 
particular, environmental factors would seem to stress genetically determined variations of the 
immune response responsible for an altered control of the response to the microbiota. At the same 
time, the action of environmental factors or the subsequent alterations of the immune response to the 
microbiota  seems  to favor the emergence of potentially pathogenic strains (the so-called 
pathobionts) that would contribute to the chronicization of the inflammation. All the aforementioned 
components, microbiota, environmental factors, immune response and genetic susceptibility 
contribute with mutual interactions to the onset of a clinically manifest disease (Figure 8). 
 
Figure 8. Interaction of various factors that contribute to IBD in a genetically susceptible host 
organism. (Sartor R.B., Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407) 
 
Genetic alterations: 
Even though the precise etiology of IBD is so far still not clear, genetic analyses of familial 
aggregation and concordance studies of monozygotic twins have highlighted that genetic 
determinants play a role in both the penetrance of the disease and its heterogeneity. Linkage and 
familial association studies have allowed the identification of a variety of loci responsible for IBD 
susceptibility. 
Quite recently, following  the introduction of Genome-wide association studies for the identification 
of single nucleotide polymorphisms (SNPs) associated with a greater frequency of the onset of 
certain diseases, numerous variations associated with a greater risk of developing Crohn’s disease 
and ulcerative colitis were identified in patients suffering from IBD. The genes that are involved 
range from those implicated in the intestinal permeability to those concerning the immune response. 
The identification of single polymorphisms in the NOD2 gene has represented the first recognized 
risk factor for Crohn’s disease. 
Nowadays, the CARD15/NOD2 gene is viewed as the main gene involved in CD. Considering the 
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gene variants identified in the NOD2 gene, three are associated with the susceptibility to CD and are 
present in about 40% of patients. The NOD2 gene is formed by 11 constant exons and a twelfth 
alternative exon in region 5. NOD2 encodes a protein of 1,040 amino acids containing various 
functional domains. Over 30 mutations affecting the entire NOD2 gene have been identified. Out of 
these 30 genetic variants, three have proved to be independently associated with the susceptibility to 
CD and represent 82% of the chromosomal mutations.  
These three allelic variants are: 
- R702W (C2104T), positioned on exon 4;  
- G908R (G2722C), positioned on exon 8; 
- 1007fs (3020insC), positioned on exon 11. 
The first two mutations may be considered non-conservative missense mutations. They have also 
been identified as disease-causing mutations, even though they do not induce structure 
modifications as the 3020insC variant does. Besides, 27 additional minor and rare mutations have 
been classified as mutations that could cause diseases (DCMs). The Leul007fiC (3020InsC) 
mutation determines the formation of a truncated protein lacking 33 distal amino acids in the LRR 
domain that entails a loss of the functional activity of the protein. 
The other mutations are 2104 T~C, which causes the replacement of arginine 702 by a residual of 
tryptophan (R702W), and 2722 G~C, which causes the replacement of a glycine by an arginine at 
position 908 (G908R). These variants modify the proteinic composition and, therefore, interfere 
with the binding to MDP. 
 
Microbiota Alterations 
A huge number of micro-organisms are known to colonize the gut and to form complex 
communities or microbiota. The host-microbiota associations usually evolve maintaining a good 
relationship. Bacteria provide the gastrointestinal tract with nutritive substances and carry on the 
function of preventing the colonization by pathogenic opportunists. Furthermore, they contribute to 
the anatomic development and  functioning of the mucosal immune system (Duerkop B.A et al., 
2009). In adults, the “normal” microbiota comprises not only bacterial species that support anti-
inflammatory responses but also micro-organisms that, under special conditions, can cause 
inflammation (Round J.R. and Mazmanian S.K., 2010). Therefore, microbiota has the potential to 
evoke both pro and anti-inflammatory responses and the composition of the bacterial communities 
in the intestine is connected with the perfect operation of the immune system (Round J.R. and 
Mazmanian S.K., 2009). Both a decrease in the phyla Firmicutes and Bacteroidetes and a reduction 
of the member diversity were observed in patients with inflammatory bowel diseases (Frank D.N. et 
al., 2007). Recently, a reduction of the bacterium Faecalibacterium prausnitzii, belonging to phyla 
Firmicutes, was associated with an early post-operative recurrence in patients with CD (Sokol H. et 
al., 2008). Other studies have reported that a subset of people with Crohn’s disease harbor a strain 
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of potentially invasive Escherichia coli in their small intestine (Pineton de Chambrun G. et al., 
2008). 
An altered balance of beneficial versus aggressive microbial species could lead to a 
proinflammatory luminal milieu that drives chronic intestinal inflammation in a susceptible host. 
Numerous studies have implicated several commensal organisms, such as E. coli, Bacteroides, 
Enterococcus and Klebsiella species, in the pathogenesis of human IBD. By contrast, various 
Lactobacillus and Bifidobacterium species have predominantly protective effects and have been 
used therapeutically as probiotics (Sartor R.B., 2004). Several groups showed alterations of the 
microbial luminal mucosally-adherent flora in patients with Crohn disease, ulcerative colitis and 
pouchitis (Swidsinski A. et al., 2002; Sartor R.B., 2004). 
A fundamental and still unsolved problem is whether dysbiosis is a factor of primary or secondary 
predisposition for IBDs, since it may be related to other defects or compounded by them. Recent 
studies have shown that dysbiosis is affected by both the genotype of the host, such as the presence 
of alleles of susceptibilities (for instance NOD2 or ATG16L1), and the IBD phenotype (a more 
significant difference is reported in patients with ileal Crohn’s disease with respect to the controls). 
It should be considered that major commensal organisms belonging to the Clostridiales order, such 
as Faecalibacterium and Roseburia, appeared to be significantly reduced in patients with ileal 
Crohn’s disease (Frank D.N. et al., 2011; Willing B.P. et al., 2010). These genii are considerable 
sources of short chain fatty acids, such as butyrate, which have proved to play a protective role in 
the murine models of colitis. Furthermore, Clostridium Clusters IV (including Faecalibacterium) 
and XIV were recently shown to induce the accumulation of Treg FOXP3+ cells in murine colon 
(Atarashi K. et al., 2011). 
Dietary components can alter the composition and virulence of enteric commensal bacteria, 
providing a potential explanation for the increase in the incidence of IBD in Western countries in 
the second half of the twentieth century and, more recently, in Eastern countries, as they adopt 
Western dietary practices. The dietary components can achieve opposite effects. For instance, short-
chain fatty acids, especially butyrate, are the preferred metabolic substrates of colonocytes, and can 
positively affect the mucosal barrier. Iron stimulates growth and virulence of intracellular bacteria, 
whereas aluminum is an adjuvant for bacterial stimulation of immune responses (Perl D.P. et al., 
2004). 
 
Epithelial barrier and immune response alterations 
It is believed that a few defects affecting the intestinal barrier, such as an increase in the intestinal 
permeability and/or a defective repair of epithelial cell after transitory damages, may induce the 
onset of IBDs by favoring a greater passage of luminal antigens. Environmental factors, such as 
intercurrent infections or the use of nonsteroidal anti-inflammatory drugs specifically acting at this 
level could represent the cause setting off the onset of IBD. The inflammatory response in IBD is 
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characterized by an increased production of proinflammatory cytokines (TNF-α, IL-6, IL-1β) 
supported by cytokines produced by T cells. In CD, IL-12/23 stimulates the production of IFN-γ, 
which plays a leading role in giving rise to the (Th1-mediated) inflammation. In UC, the increased 
production of IL-5 and IL-13 plays a leading pathogenetic role in the genesis and chronicization of 
the (Th2-like-mediated) inflammation (Fuss I.J. et al., 1996, 2004; Bouma G. and Strober W., 
2003). 
A high expression of IL-17 and IL-23 has been found in CD and UC (Rovedatti L. et al., 2009), 
even though it would seem that IL-23 regulates the Th effector subsets in a different way in CD and 
in UC, increasing the IFN-γ (Th1 cytokine) production by T CD4 cells + of the lamina propria in 
patients with CD and the production of IL-17 in UC (Kobayashi T. et al., 2008). The chronicization 
of the inflammation is also supported by the presence of a relatively inadequate regulatory response. 
In fact, it has been shown that, in active IBDs, the effector cells have an increased SMAD7 (an 
intracellular inhibitor of TGF-β signaling) expression that is likely to prevent the TGF-β-mediated 
suppression effect of the regulatory T cells (Monteleone G. et al., 2001; Boirivant M. et al., 2006). 
Therefore, during the active phases of the disease, the regulatory response could prove ineffective in 
consequence of the presence of effector cells resistant to the inhibition of the regulatory cells. In 
short,  results achieved up to now show that in IBD there is an increase in the inflammatory 
infiltration with an increase in the local production of proinflammatory cytokines with respect to the 
controls. Quite recently, an insufficient acute inflammatory response has been observed in patients 
with CD, leading to the development of chronic inflammation as a result of the partial inefficiency 
of the innate response (Smith A.M. et al., 2009). 
 
Environmental triggers 
Studies have implicated several environmental triggers in the pathogenesis of IBD. These factors 
include smoking, which is protective in ulcerative colitis but detrimental in Crohn's disease, diet, the 
use of antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs), stress and infection. 
Unfortunately, the mechanisms by which these factors initiate the onset of disease or reactivate 
quiescent IBD are not well understood. These triggering factors alter mucosal barrier integrity, 
immune responses, or the luminal microenvironment, each of which have an impact on 
susceptibility to inflammation. 
Infection and NSAIDs can transiently initiate an acute inflammation, break the mucosal barrier and 
activate innate immune responses. 
Smoking is perhaps the most thoroughly documented environmental contributor to IBD, but its 
opposite effect on Crohn's disease and ulcerative colitis, respectively, is difficult to understand. 
Nicotine, carbon monoxide and hypoxia have all been suggested to be mediators of the effects of 
smoking on IBD (Birrenbach T. and Bocker U., 2004; Cosnes J., 2004). 
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2. AIM 
 
In these studies, we meant to investigate the relationships between intestinal microbiota and immune 
mucosal response. In particular, we delved into the immune mucosal response to the increase in 
intestinal permeability, a condition that is normally considered to promote a local and systemic 
inflammatory response to an increased load of the bacterial components of the microbiota. 
In fact, the increase in intestinal permeability is considered a condition that contributes to the 
pathogenesis of the inflammatory bowel diseases (ulcerative colitis and Crohn’s disease), and the 
NOD2 gene polymorphism, considered a risk factor for the onset of Crohn’s disease, is associated 
with the presence of an increased intestinal permeability not only in patients, but also in relatives 
who are carrier of the same genetic polymorphism. Therefore, in these studies we have investigated 
the mucosal response mechanisms that follows a  transitory increase in the permeability of the 
epithelial colon barrier. We performed our studies  in control mice,  and in mice with deletion of the 
Nod2 gene. 
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Abstract 
 
Background and Aims: Previous studies have indicated that a defective epithelial barrier leads to 
inflammation of the underlying lamina propria. Nevertheless, it is likely that physiologic breaks in 
the barrier must occur for homeostatic regulatory T cells to develop. We determined the effect of 
agents that disrupt epithelial tight junctions (ethanol and AT1002, a Vibrio cholerae zonula 
occludens toxin hexapeptide) on regulatory T-cell induction and resistance to induction of colitis 
by trinitrobenzene sulfonic acid (TNBS). Methods: The effects of ethanol and AT1002 on colon 
immune function were evaluated by their capacity to induce direct phenotypic or functional 
changes in effector and regulatory cell populations and their indirect effect on the development of 
TNBS-induced colitis. The basis of regulatory cell development was evaluated with in vitro studies 
of isolated dendritic cell populations. The role of innate immunity was evaluated by in vivo gene 
silencing studies utilizing Toll-like receptor (TLR)-2-specific small interfering RNA (siRNA). 
Results: Both ethanol and AT1002 induced persistent latencyassociated peptide-positive CD4+ 
regulatory T cells that, as shown in adoptive transfer studies, render mice resistant to the induction 
of TNBS colitis. The development of these cells requires the presence of an intact microflora and 
the activity of CD11c+ dendritic cells. Their induction is also influenced by innate immune factors 
operating through TLR-2, because attenuation of TLR-2 signaling by in vivo TLR-2 siRNA 
administration prevents their development. Conclusion:  A mild and/or transient breach in 
epithelial barrier function leads to dominant regulatory T-cell responses that protect the mucosa 
from inflammation. 
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Introduction 
 
The commensal organisms of the gut microflora act via a number of mechanisms to reduce 
colonization of the mucosal surface by pathogenic organisms and the inflammation caused by these 
organisms.1 However, if and when these organisms penetrate the epithelial cell layer they are 
themselves able to cause inflammation.  This was shown over a decade ago with mice that exhibit 
inflammation in areas subjacent to epithelium with tight junction disruption due to expression of a 
dominant N-cadherin.2 More recently, an inflammatory state with a similar pathogenesis was 
observed in mice with epithelial cell-specific NEMO deficiency and thus defective NF-κB function 
that manifest impaired epithelial barrier function due to epithelial cell apoptosis and ulcer 
formation.3 These and similar findings lead to the view that an intact epithelium is a bulwark 
against the development of GI inflammation and that various types of epithelial cell defects that 
impairs barrier function is a potential cause of such inflammation.4 It is important to note, however, 
that the normal epithelium does allow limited exposure of mucosal immune elements to antigens in 
the commensal microflora.5 One possible reason for this apparent subversion of epithelial cell 
barrier function may be the need of the mucosal system to develop immunological tolerance toward 
antigens in the commensal microflora, since in the absence of such tolerance mucosal inflammation 
is likely to occur.  
In the present study, we investigated this possibility by asking if a transient increase in mucosal 
permeability induced by either rectal administration of ethanol or a Vibrio Cholerae zonula 
occludens toxin hexapeptide (AT1002) (the latter a substance that specifically affects tight junction 
integrity) would have any effect on the subsequent ability to induce and sustain (TNBS)-induced 
colitis.  We found that both types of treatment, while itself inducing a mild and transient 
inflammatory response, led to the induction of regulatory T cells and a state of resistance to the 
induction of TNBS-colitis. These findings thus provide formal proof that limited exposure of the 
mucosal immune system to the microflora is an important mechanism of tolerance induction.  
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Materials and Methods 
 
Mice 
Studies were performed in 5- to 6-week-old male SJL or C57BL10 mice obtained from Charles 
River (Calco, Italy), Harlan (S. Pietro al Natisone [UD], Italy), or Jackson Laboratories (Bar 
Harbor, ME) and maintained in the animal facilities at the Istituto Superiore di Sanità (Rome, Italy) 
or at the National Institute of Allergy and Infectious Diseases, National Institutes of Health 
(Bethesda, MD). All animal studies were approved by the Animal Care and Use Committees of the 
Istituto Superiore di Sanità and the National Institutes of Health. 
 
 
Study Design  
Mice were administered either 50% ethanol or AT1002 (250 µg/mouse in 150 µL of phosphate-
buffered saline) (the latter kindly provided by A. Fasano, University of Maryland School of 
Medicine, Baltimore, MD) via a 3.5F catheter inserted into the rectum as previously described.6 
Mouse weight changes and histologic appearance of the colonic tissue were then determined at 
various time points. In some experiments, mice were killed at appropriate time points to obtain 
lamina propria mononuclear cells (LPMCs) for various studies described in the text. For studies of 
effects of epithelial barrier disruption on colitis, mice administered 50% ethanol, AT1002, or no 
treatment were subsequently administered TNBS 2.5 mg delivered in 150 µL of 50% ethanol 
(Sigma-Aldrich, St. Louis, MO and Fluka, Milan, Italy) per rectum as previously described.6 The 
occurrence and course of colitis in the different groups of animals were evaluated as described in 
the text.  
 
Isolation and Culture of Lamina Propria Mononuclear Cells (LPMC)  
 
LPMCs were isolated from freshly obtained colonic specimens using a modification of the method 
described by van der Heijden and Stok.7 In some experiments, CD11c+ and CD4+ cells were 
purified by magnetic cell sorting using CD11c (N418) microbeads or a CD4+ T-cell Isolation Kit 
(Miltenyi Biotec, Calderara di Reno, Italy or R&D Systems, Minneapolis, MN) following the 
manufacturer’s instructions. The purity of LPMC CD11c+ and CD4+ cells was >90% and >95%, 
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respectively, as assessed by immunofluorescence staining. To measure the capacity of LPMCs to 
produce T-cell cytokines, the LPMCs were cultured at 1 x 106 cells/mL in 48-well plates (Costar; 
Corning Inc, Turin, Italy) coated or uncoated with murine anti-CD3e antibody (clone 145-2C11; 
BD-PharMingen, San Diego, CA) and containing complete media supplemented with 1 µg/mL of 
soluble anti-CD28 antibody (clone 37.51; PharMingen) as previously described.6 To measure the 
capacity of LPMCs to produce interleukin (IL)-12p70, the LPMCs were cultured at 1 x 106 
cells/mL in 48-well plates in media containing Staphylococcus aureus Cowan strain I (1:10,000; 
Calbiochem, Gibbstown, NJ), and interferon (IFN)-γ (1000 U; R&D Systems). After 48 hours of 
culture, supernatants were harvested and assayed for the presence of cytokines (IL-12p70, IFN- γ, 
IL-10) by enzyme-linked immunosorbent assays, conducted as previously described.6 
 
In Vitro Stimulation of  CD4+ Lamina Propria T Cells by CD11c+ Lamina Propria Dendritic Cells 
 
LPMCs obtained from 50% ethanol-treated or untreated mice were subjected to magnetic bead 
sorting (Miltenyi Biotec) to obtain CD11c+ and CD4+ cells. A total of 2 x 105/mL of the CD4+ cells 
from untreated mice was cocultured with 1 x 105/mL CD11c+ cells from 50% ethanol–treated mice 
or from untreated mice in the presence or absence of 20 µg/mL of anti-IL-10R monoclonal 
antibody (1B1.3; DNAX Research, Palo Alto, CA). At the end of 48 hours of culture, the cells were 
collected, washed, and stained for latency-associated peptide (LAP) expression. 
 
LPMC Immunofluorescence Staining  
 
Freshly isolated and washed LPMCs were subjected to Fc block with anti-CD16/CD32 (BD 
PharMingen) and then stained with biotinylated anti-LAP (affinity-purified biotinylated goat anti-
LAP polyclonal antibody; R&D Systems) or biotinylated normal goat immunoglobulin G (R&D 
Systems) as previously described.6 In some experiments, intracellular Foxp3 expression was 
evaluated using the APC anti-mouse/rat Foxp3 Staining Set (eBioscience, San Diego, CA) 
following the manufacturer’s protocol. 
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Intestinal Permeability Studies 
 
To measure colonic permeability, mice were administered 50% ethanol per rectum. At daily time 
points, mice then received per rectum 2 mg/10 g body wt fluorescein isothiocyanate-conjugated 
dextran dissolved in purified water (4000 mol wt; Sigma-Aldrich). Whole blood was obtained via 
eye bleed 1 hour after fluorescein isothiocyanate dextran administration. Blood samples were 
heparinized and centrifuged at 3000 rpm to obtain sera; the latter was then analyzed by fluorometry 
using a Victor3 (485/535 nm, gain 1480) plate reader (Perkin-Elmer, Waltham, MA). 
 
Depletion of Gut Commensal Microflora 
 
Depletion of gut microflora was accomplished as previously described by the administration of 
ampicillin (1 g/L; Pharmacia, Milan, Italy), vancomycin (500 mg/L), neomycin sulfate (1 g/L), and 
metronidazole (1 g/L) in drinking water for 4 weeks.8 Evaluation of the effect of antibiotic 
treatment on intestinal microflora was per formed with standard microbiological methods by 
Plaisant srl (Rome, Italy). Briefly, fecal matter was removed from colons using sterile technique, 
placed in 15 mL conical tubes with thioglycolate, weighed, and vortexed until homogeneous. 
Contents were diluted and plated on universal and differential media for the growth of anaerobes 
and aerobes. Colonies were counted after incubation at 37 °C for 48 hours (aerobes) and 72 hours 
(anaerobes). After counting, colonies were picked and identified by biochemical analysis, 
morphologic appearance, and Gram staining. 
 
Adoptive Transfer of LPMC or Lamina Propria CD4+ Cells Depleted of LAP-Positive T Cells 
 
LPMCs or lamina propria (LP) CD4+ T cells isolated from the colons of mice treated with 50% 
ethanol were depleted of LAP-positive cells by using a CELLection Biotin Binder Kit (Dynal 
Biotech ASA, Invitrogen SRL, San Giuliano Milanese, Italy). A total of 3.0 x 105 LPMCs, LP 
CD4+ T cells, LAP cell-depleted LPMCs, or LAP-depleted LP CD4+ T cells were injected via tail 
vein as described.6 
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Histological Assessment of Colitis  
 
Tissues removed from mice at indicated time points were fixed in 10% neutral buffered formalin 
solution (Sigma-Aldrich) and then embedded in paraffin, cut into tissue sections, and stained with 
H&E. Stained sections were examined for evidence of colitis using criteria described in detail 
previously.6 
 
In Vivo Inhibition of Toll-like Receptor 2 by Administration of Toll-like Receptor 2-specific Small 
Interfering RNA 
 
Sequences of toll-like receptor (TLR)-2–specific small interfering RNA (siRNA) for use in TLR2 
silencing studies (Dharmacon, Lafayette, CO) were as follows: 5’- 
UCAAUGGGCUCGGCGAUUUUU-3’ and 5’-AAGAUGCGCUUCCUGAAUUUU-3’. The 
sequence for the control siRNA was as follows: 5’-UAAGGCUAUGAAGAGAUACUU- 3’. For in 
vivo transfection, 1 mg of siRNA was encapsulated in HVJ-E vector as previously described.9 Mice 
were administered siRNA according to protocols described in the text. 
 
Western Blot  
 
Western blot was performed with the lysates of adherent splenocytes using rabbit anti-mouse TLR2 
or TLR4 antibodies (eBioscience) and horseradish peroxidise-conjugated anti-rabbit  
immunoglobulin G antibody. 
 
Statistical Analysis 
 
Assessment  of   statistical  differences   was   determined   by   parametric   Student   t   test      and 
nonparametric  Mann-Whitney  test  as  appropriate.
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Results 
 
Intrarectal Ethanol Administration Leads to Mild Colonic Inflammation and Increased Colonic 
Permeability 
 
Whereas induction of hapten-induced colitis requires administration of the hapten in an ethanol 
carrier to break the epithelial barrier, we reasoned that administration of ethanol in the absence of 
the effector cell stimulant (the hapten) may have a contrary effect: the induction of regulatory cells. 
In initial studies to investigate this possibility, we determined the effect of intrarectal 
administration of 50% ethanol in distilled water (50% ethanol) (150 µL), the same dose of ethanol 
normally used to induce TNBS colitis. As shown in Figure 1A and B, such ethanol administration 
resulted in a small but transient loss of weight compared with (untreated) control mice. This was 
accompanied at day 3 by the transient appearance of a mild inflammatory infiltrate in the colonic 
LP, as well as scattered (mild) epithelial cell disruption that resolved by day 7. In addition, as 
shown in Figure 1C, the infiltrating LPMCs were capable of producing significantly increased 
levels of IFN-γ and IL-10, but not IL-4 (the latter data not shown), as compared with cells extracted 
from control mice. Of interest, substantial amounts of IL-10 were secreted by unstimulated cells, 
suggesting that such IL-10 was being produced by cells activated in vivo. Finally, as shown in 
Figure 1D, this inflammatory response to intrarectal ethanol administration was accompanied by a 
transient change in colonic permeability, as measured by dextran/fluorescein isothiocyanate uptake 
into the circulation. In related studies, we also determined the effect of a second rectal 
administration of 50% ethanol 12 days after the initial administration. As shown in Supplementary 
Figure 1A and B (see Supplementary material online at www.gastrojournal.org), the second 
administration induced effects similar to those observed after the first administration, although in 
this case the inflammation induced was somewhat diminished. 
 
 
Intrarectal Ethanol Administration Is Accompanied by the Induction of LAP-Positive CD4+ T Cells     
 
In further studies, we determined the percentage of cells in the LP bearing markers associated with 
regulatory T cells. As shown in Figure 2, 3 days after intrarectal ethanol administration, there was a 
significant increase in the proportion of both CD4+CD25+ T cells and CD4+ T cells bearing latent 
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transforming growth factor (TGF)-β (LAP) on their cell surface (CD4+ LAP-positive T cells) 
compared with LP cells from control mice not treated with ethanol. These cell populations were 
partially overlapping in that only about 25% of the LAP-positive cells were also CD25+ in LPMCs 
obtained from both mice treated and not treated with ethanol (data not shown). Cells with a similar 
array of markers were seen after a second administration of ethanol (Supplementary Figure 1C; see 
Supplementary material online at www.gastrojournal.org). 
 
Because Foxp3 is a transcription factor associated with a major type of regulatory T cell, we also 
determined Foxp3 expression in the CD4+CD25+ and CD4+ LAP positive T-cell populations 
appearing in the LPMCs after ethanol administration. We found that Foxp3 was coexpressed in 
76% and 78% of CD4+CD25+ LP T cells in the LPMCs of untreated mice and ethanol-treated mice, 
respectively. In contrast, as shown in a representative study depicted in Supplementary Figure 2 
(see Supplementary material online at www.gastrojournal.org), Foxp3 was coexpressed in only 
7%-13% and 9%-18% of CD4+ LAP-positive LP T cells from untreated and ethanol-treated mice, 
respectively. 
 
To further characterize the ethanol-induced LAPpositive T-cell population, we performed marker 
studies on LPMCs obtained 3 days after ethanol administration, before and after in vitro depletion 
of LAP-positive T cells. We found that LPMCs after depletion exhibited a 50% reduction in the 
number of cells expressing LAP, but no change in the number of cells expressing Foxp3, and thus 
obtained further evidence that the LAP-positive T cells were largely Foxp3 negative (data not 
shown). In addition, the LPMCs after depletion exhibited an approximately 75% reduction in ex 
vivo production of IL-10 or TGF-β as compared with LPMCs before depletion; this suggested that 
LAP-positive T cells were also producers of these cytokines (data not shown). 
 
 
Ethanol Administration Renders Mice Resistant to the Subsequent Induction of TNBS-Induced 
Colitis via the Induction of LAP-Positive  CD4+ T Cells 
 
In further studies, we tested whether the regulatory T cells appearing after ethanol administration 
influence the severity of subsequently induced TNBS colitis. Accordingly, we compared the 
severity of colitis in mice with TNBS-induced colitis that were pretreated with intrarectal 50% 
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ethanol 12 days before with the severity of colitis in mice with TNBS-induced colitis not so 
pretreated. As shown in Figure 3A and B, mice pretreated with ethanol exhibited less severe 
TNBS-induced colitis, as indicated by their significantly lower loss of body weight, decreased 
histologic evidence of intestinal inflammation, and lower colitis scores, compared with mice not 
pretreated with ethanol. In addition, as shown in Figure 3C, cytokine production by LPMCs 
obtained from mice pretreated with ethanol exhibited a significant reduction in in vitro IFN-γ 
secretion compared with mice not pretreated with ethanol. Finally, observation of mice protected 
from induction of colitis for 7–10 days following resolution of colitis disclosed that pretreatment 
with ethanol did not lead to delayed induction of colitis. 
 
In additional studies shown in Supplementary Figure 3 (see Supplementary material online at 
www.gastrojournal.org), we found that (1) the protective effect of ethanol administration was quite 
prolonged in that at least partial protection was still noted 5 weeks after such administration; (2) as 
shown in Supplementary Figure 4 (see Supplementary material online at www.gastrojournal.org), 
protection was not strain specific because it was also seen in C57BL/10 mice; and (3) as shown in 
Supplementary Figure 5 (see Supplementary material online at www.gastrojournal.org), correlating 
with the fact that ethanol administration is associated with increased ethanol administration in IL-
10-deficient C57BL/10 mice did not lead to protection from subsequent induction of TNBS colitis. 
 
To determine if the previously described ethanol-induced resistance to TNBS-induced colitis was 
indeed due to regulatory T cells, we next performed cell transfer studies in which naive mice were 
adoptively transferred LPMCs or purified LP CD4+ T-cell populations from ethanol-treated mice 
before induction of TNBS colitis. In these studies, the transferred cells were 65%-80% depleted of 
LAP-positive cells as determined by flow cytometric studies. As shown in Figure 4A and B and 
Supplementary Figure 6 (see Supplementary material online at www.gastrojournal.org), naive SJL 
mice administered LPMCs or purified LP CD4+ T cells obtained from ethanol-treated mice and 
then depleted in vitro of LAP-positive cells exhibited a similar severity of TNBS-induced colitis as 
control mice administered LPMCs from mice with TNBS-induced colitis or mice with TNBS-
induced colitis who had not been subjected to ethanol pretreatment or cell transfer. In contrast, 
mice administered LPMCs or purified LP CD4+ T cells from ethanol-treated mice not depleted of 
LAP-positive cells exhibited a reduced severity of colitis. Finally, as shown in Figure 4C, the effect 
of transfer of LPMCs or CD4+ T cells or these cells depleted of LAP-positive cells from ethanol-
treated mice correlated with in vitro LPMCs or CD4+ T-cell production of both IL-12p70 and IFN-
γ. It should be noted, however, that despite the use of very large numbers of mice, the number of 
data points obtained in these cytokine studies was limiting and could not be subjected to statistical 
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analysis; thus, these data are supportive of the statistically validated weight and colitis score data 
but are not in themselves definitive. 
Taken together, these studies provide strong evidence that intrarectal ethanol administration 
induces LAP-positive CD4+ regulatory T cells that then render mice resistant to the induction of 
TNBS colitis. 
 
Induction of Transient Tight Junction Porosity in the Absence of Epithelial Damage by AT1002 
Also Confers Resistance to Induction of TNBS Colitis 
 
Intrarectal administration of 50% ethanol caused only minimal morphologic changes in the 
epithelial layer, so its ability to alter gut permeability was presumed to be due mostly to its 
previously observed effect on the integrity of tight junctions.10 To obtain independent evidence that 
loss of tight junction integrity was sufficient to lead to expansion of regulatory cells and resistance 
to TNBS-induced colitis, we determined if pretreatment with an agent with a focused effect on tight 
junction integrity, the hexapeptide active domain of the V cholerae zonula occludens toxin AT 
1002, caused the same effects as pretreatment with ethanol.11,12 Accordingly, we subjected mice to 
intrarectal administration of AT1002 (250 µg in 150 µL phosphate-buffered saline) based on a 
previously established protocol for inducing increased intestinal permeability but no epithelial cell 
damage with this agent.11,12 We found that intrarectal administration of AT1002 did not result in a 
loss of body weight (data not shown) and, likewise, as shown in Figure 5A, was accompanied by a 
mild LP inflammation without morphologic evidence of epithelial cell damage. However, as shown 
in Figure 5B and C, LPMCs obtained from mice 3 days after administration of AT 1002 did exhibit 
a mild increase in in vitro IFN-γ and IL-10 production as well as a significant increase in the 
percentage of CD4+ LAP-positive T cells in the LPMC population. Finally, as shown in Figure 5D 
and E, mice pretreated with AT1002 and then administered TNBS 12 days later to induce TNBS 
colitis exhibited less severe TNBS colitis than untreated mice. These data show that changes in 
epithelial barrier function specifically due to a transient change in the integrity of the epithelial 
tight junctions are sufficient to cause the generation of LP LAP-positive T cells and the associated 
increased resistance to the development of TNBS colitis.  
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CD4+LAP-Positive  Cells Expansion Is Dependent on the Presence of an Intact Bacterial Flora 
  
To evaluate the influence of bacterial flora on ethanol-induced increases in LP LAP+ cells, we 
treated a group of mice for 4 weeks with a cocktail of 4 antibiotics (see Materials and Methods) to 
partially sterilize the gastrointestinal tract before the administration of 50% ethanol. Such treatment 
led to an approximately 100-fold decrease (as measured by colonyforming units in samples of 
material from various parts of the colon) in both aerobic and facultative anaerobic bacteria; in 
addition, as assessed by standard bacteriologic studies, the residual flora was not qualitatively 
changed. As shown in Figure 6A, antibiotictreated mice lost significant weight following ethanol 
administration, and unlike mice not given antibiotics, they did not return to normal weight after 7  
days. In addition, as shown in Figure 6B, the extracted LP population of antibiotic-treated mice 
displayed no increase in LAP-positive cells and, as shown in Figure 6C, transfer of LPMCs from 
these mice to recipients did not confer protection from TNBS-induced colitis. Thus, intrarectal 
administration of 50% ethanol requires the presence of an intact microflora for the induction of 
LAP-positive cells. 
 
Myeloid Dendritic Cells Induce the Expansion of CD4+ LAP-Positive T Cells  
 
In further studies to determine the role of myeloid dendritic cells (DCs) in the protective effect 
induced by ethanol, we purified CD11c+ DCs from LPMCs isolated from ethanol-treated and  
untreated mice and then cultured the DCs thus obtained with purified CD4+ T cells from LPMCs 
isolated from naive untreated mice. Then, at the end of the culture period, we determined the 
number of LAP-positive cells by flow cytometry. As shown in Figure 7, in 2 independent studies, 
coculture of CD11c+ DCs isolated from ethanol-treated mice with naive CD4+ T cells, with no 
other stimulation in vitro provided, was associated with a higher percentage of LAP-positive cells 
as compared with the percentage of LAP-positive cells from coculture of CD11c+ DCs isolated 
from untreated mice with naive CD4+ T cells. Of interest, this CD11c+ DC effect was dependent on 
the availability of IL-10 because addition of anti-IL-10R antibody prevented the increase in the 
number of LAP-positive cells (data not shown). These data suggest that myeloid DCs are 
responsible for the induction of CD4+ LAP-positive cells. 
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TLR2 Signaling Is Critical for the Generation of LAP-Positive Regulatory Cells  
 
Prior studies have established that TLR signalling is necessary for induction of regulatory T cells in 
mucosal tissues.13,14 To examine the role of one such TLR, TLR2, in ethanol-induced induction of 
regulatory T cells, we determined the ability of mice with reduced TLR2 expression due to in vivo 
administration of TLR2-specific siRNA to develop regulatory T cells upon intrarectal ethanol 
administration. Accordingly, mice were pretreated with 100 µg of either TLR2-specific or control 
siRNA on the day before and on the day of intrarectal ethanol administration. As shown in Figure 
8A, by Western blot analysis of spleen whole cell lysates, mice administered TLR2-specific siRNA 
exhibited decreased TLR2 but not TLR4 expression. As shown in Figure 8B, mice pretreated with 
TLR2-specific siRNA, but not control siRNA, exhibited a more protracted loss of weight upon 
intrarectal ethanol administration compared with mice treated with ethanol alone. In addition, as 
shown in Figure 8C, mice pretreated with TLR2-specific siRNA and killed at day 4 after ethanol 
administration did not exhibit a significant increase in CD4+ LAP-positive LP T cells, whereas 
mice pretreated with control siRNA exhibited a significant increase. This correlated with the fact 
that, as shown in Figure 8D, LPMCs from mice administered TLR2-specific siRNA exhibited 
reduced IL-10 but no change in IFN-γ production upon stimulation with anti-CD3/anti-CD28 in 
vitro as compared with mice administered control siRNA. Finally, as shown in Figure 8E and F, 
mice administered TLR2-specific siRNA in association with ethanol did not exhibit resistance to 
induction of TNBS colitis, whereas mice administered control siRNA in association with ethanol 
did exhibit such resistance. These data thus indicate that the ethanol-induced generation of LAP-
positive regulatory T cells is dependent on TLR2 signaling. 
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Discussion 
 
In light of previous data showing that disruption of the epithelial barrier leads to inflammation of 
the LP,2 it was quite unexpected that administration of 2 agents (ethanol and AT1002) that cause 
transient and mild disruption of barrier function is followed by the expansion of a persistent 
population of regulatory T cells that greatly increases resistance to the subsequent induction of 
TNBS colitis. The basis of such regulatory T-cell expansion became apparent in studies showing 
that such expansion depended on the presence of an unperturbed gut microflora and, in addition, 
was associated with the presence of LP DCs with a propensity to induce regulatory cells upon 
exposure to microflora antigens. It can therefore be concluded that transient and limited disruption 
in barrier function leads to a dominant regulatory immune response to gut microflora antigens and 
that the cross talk between the microflora and the mucosal immune system, even when somewhat 
exaggerated by epithelial barrier disruption, has a net anti-inflammatory effect.  
The nature of the regulatory T cell induced by barrier disruption was also somewhat unexpected. 
The identifying feature of this cell is its expression of surface TGF-β in the form of TGF-β bound 
to LAP. Of note, while a substantial number of the LAP-positive regulatory T cells were CD25+, a 
substantial number did not bear this marker. Perhaps more importantly, while most of the CD25+ 
cells were Foxp3 positive, most of the LAP-positive cells were Foxp3 negative. This leads to the 
possibility that most of the LAP-positive regulatory cells developing under the circumstances 
studied here were actually more closely related to the Tr-1 regulatory cell than to the “natural” 
(Foxp3+) regulatory cell, even though the latter cell has also been shown to bear surface LAP.15 
This view is favored by previous studies of regulatory LAP-positive cells developing in mice 
treated with probiotics showing that the regulatory cell involved was dependent on IL-10.6 In 
addition, it is favored by our finding that IL-10–deficient mice do not display resistance to 
induction of TNBS colitis upon intrarectal preadministration of ethanol and induction of LAP-
positive regulatory T cells by myeloid DCs in vitro is inhibited by anti-IL-10R. Finally, the 
existence of Tr-1-like regulatory cells bearing surface LAP is supported by recent studies showing 
that in vitro suppression by such cells is inhibited by anti-TGF-β as well as by studies showing that 
populations of LAP-positive cells lacking Foxp3 have suppressor function.16,17 
Extensive in vivo depletion studies showing that plasmacytoid DCs were not necessary for ethanol-
induced regulatory T cells (data not shown) led us to the supposition that myeloid DCs were 
critically necessary for such induction. This supposition was subsequently supported by in vitro 
studies showing that ethanol administration led to the appearance of myeloid DCs with the capacity 
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to induce CD4+ LAP-positive T cells. Previous studies of mucosal myeloid DC populations 
showing that mucosal DCs that produce TGF-β or that bear surface LAP support the development 
of regulatory T cells in the mucosa are in accord with this finding, although in these cases the 
regulatory cell induced was a Foxp3+ cell.18 Thus, in this case, the capacity of the inducing DC to 
produce IL-10 rather than TGF-β may be its most salient feature. This is supported by the fact that, 
as already mentioned, in vitro induction of such cells by myeloid DCs was blocked by the addition 
of anti-IL-10R to the culture. In addition, the finding that ethanol-induced regulatory cells do not 
develop in the absence of effective TLR2 signaling, a potent inducer of IL-10, also supports the 
importance of the latter cytokine in regulatory T-cell induction.  
In summary, the present studies establish that increased exposure to intestinal microflora or their 
products via a transiently disrupted epithelial barrier can have the paradoxical effect of increasing 
the resistance of the mucosa to inflammation via the induction of regulatory T cells. Such cells then 
have the capacity to protect mice against the development of TNBS-induced colitis, a mucosal 
inflammation depending on both innate and adaptive immune responses. This finding is important 
to our understanding of the origin of human inflammatory bowel disease because it is assumed by 
some investigators that subtle changes in barrier function alone may be a cause of such disease. On 
the contrary, these findings suggest that in some cases subtle changes may have a protective effect. 
 
Supplementary Data 
Note: To access the supplementary material accompanying this article, visit the online version of  
Gastroenterology at www.gastrojournal.org, and at doi: 10.1053/j.gastro.2008.07.028. 
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Figure Legends 
 
Figure1. Effects of intrarectal administration of 50% ethanol (150 µL). (A) Weight curves of 
ethanol-treated and untreated mice. Each point represents the cumulative mean weight ± SE from 3 
independent experiments, each consisting of groups of 10 mice. *P<.05, ethanol-treated mice 
versus untreated mice. (B) Representative H&E-stained microscopic sections (original 
magnification x50) of colon at different time points after ethanol administration: (a) ethanol-treated 
mouse at day 1, (b) day 3, (c) day 5, and (d) day 7after intrarectal ethanol administration. (Inset) 
Microscopic view of epithelium (x400). (C) In vitro IFN-γ and IL-10 production by LPMCs 
isolated from the colons of SJL mice 3 days after ethanol administration. Cultures were performed 
in the absence of any stimulant (open bars) or in the presence of anti-CD3/CD28 (closed bars). 
Data represent the mean ± SE from 3 independent experiments. In each experiment, cultures of  
pooled cells extracted from 5 mice per group were performed. IFN-γ, P = .02 anti-CD3/28 
stimulated cells from 50% ethanol–treated versus untreated mice; IL-10, P = .03 unstimulated cells 
from 50% ethanol–treated versus untreated mice, P = .007 anti-CD3/28 stimulated cells from 50% 
ethanol–treated versus untreated mice. (D) Intestinal permeability as measured by rectal 
administration of fluorescein isothiocyanate/dextran. *P < .05 versus day 0. 
 
Figure 2. Effect of a single intrarectal administration of 50% ethanol on the generation of 
CD3+CD4+ LP T cells expressing CD25 and LAP. Mice were killed at day 3 after treatment. Data 
indicate the percentage of positive cells in the CD3+CD4+ gated population. The percentage of 
CD4-positive cells was not statistically different in the 2 groups (ethanol-treated mice, 32.9% ± 
3.18%; untreated mice, 34.16% ± 4.8%). 
 
Figure 3. Effect of intrarectal administration of 50% ethanol on induction of TNBS colitis. (A) 
Weight changes of mouse groups after TNBS administration. Each point represents the cumulative 
mean weight (±SE) from 5 separate experiments. In each experiment, each group consisted of at 
least 5 mice. *P< .05, 50% ethanol-pretreated mice versus untreated mice. (B) Histologic 
evaluation of the effect of preadministration of 50% ethanol on subsequent TNBS-induced colitis. 
Mice were killed at 3 days after TNBS administration. (a) Photomicrograph (original magnification 
x50) of an H&Estained paraffin section of a representative colon from a mouse after induction of 
TNBS colitis. (b) Photomicrograph (original magnification x50) of an H&Estained paraffin section 
of a representative colon from a mouse after induction of TNBS colitis following preadministration 
of 50% ethanol. Histologic scores (see scoring crit
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various groups of mice after induction of TNBS colitis; each group consisted of 5 mice. (C) In vitro 
IFN-γ production by LPMCs isolated from the colons of mice on day 3 after TNBS administration. 
Cultures were performed in the absence of any stimulant (open bars) or in the presence of anti-
CD3/CD28 (closed bars). Data represent the mean ± SE from 4 independent experiments. In each 
experiment, cultures of pooled cells extracted from 5 mice per group were performed. IFN-γ, P = 
.03 anti-CD3/28 stimulated cells from 50% ethanol-pretreated versus untreated mice. 
 
Figure 4. Depletion of LAP-positive cells from donor LPMCs or purified LP CD4+ T cells of 
ethanol-pretreated mice before adoptive cell transfer abolishes the protective effect of the LPMCs. 
(A) Weight changes of groups of mouse recipients of LPMCs obtained from mice treated with 
ethanol (diamonds), recipients of LAP-positive cell-depleted LPMCs obtained from mice treated 
with ethanol (squares), recipients of LPMCs obtained from mice treated with TNBS (triangles), 
and mice treated with TNBS alone (x). Recipient mice were administered TNBS per rectum 5 days 
after adoptive transfer of LPMCs. Each experimental group consisted of at least 5 mice, and each 
data point represents the mean value ± SE for each group. Histologic scores of colons of mice in 
the various groups were obtained as described in Materials and Methods. *P <.05 mice recipients 
of Eth LPMC vs mouse recipients of Eth LPMC LAP-, TNBS LPMC, and mice treated with TNBS 
alone. (B) Weight changes of groups of mouse recipients of LPMCs obtained from mice treated 
with ethanol (diamonds), recipients of purified LP CD4+ T cells obtained from mice treated with 
ethanol (closed circles), recipients of LAP+ cell-depleted LP CD4+ T cells obtained from mice 
treated with ethanol (open circles), and mice treated with TNBS alone (x). Recipient mice were 
administered TNBS per rectum 5 days after adoptive transfer of LPMCs. Each experimental group 
consisted of at least 4 mice, and each data point represents the mean value ± SE for each group. 
Histologic scores were obtained as described in Materials and Methods. P < .05 mice recipients of 
Eth LPMC and Eth CD4+ vs mouse recipients of Eth CD4+, LAP-, and mice treated with TNBS 
alone. (C) Cytokine production by LPMCs isolated from recipient mouse colons 4 days after 
induction of TNBS colitis. Cultures were performed in the absence of any stimulant (open bars) or 
in the presence of IFN-γ–positive SAC or anti-CD3/CD28 for IL-12 and IFN-γ stimulation (closed 
bars), respectively. Data shown represent values obtained from a representative experiment of an 
LP CD4+ T-cell transfer study and 2 experiments from an LPMC transfer study. In each 
experiment, culture supernatants were obtained from pooled cells extracted from all mice per 
group. 
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Figure 5. Effect of intrarectal administration of AT1002. (A) Photomicrographs (original 
magnification x100) of H&E-stained paraffin sections of (a) an untreated colon and (b) a 
representative colon 3 days after intrarectal administration of AT1002. (B) In vitro IFN-γ and IL-10 
production by LPMCs isolated from the colons of mice on day 3 after AT1002 administration. 
Cultures were performed in the absence of any stimulant (open bars) or in the presence of anti-
CD3/CD28 (closed bars). Data represent the mean ± SE from 3 separate experiments. In each 
experiment, cultures of pooled cells extracted from 5 mice per group were performed. (C) Cells 
expressing CD25 and LAP in LPMCs isolated 3 days after AT1002 administration (closed bars) or 
untreated mice (open bars). Data indicate the percentage of positive cells in the CD3+CD4+ gated 
population. Data represent the mean ± SE from 3 separate experiments. P = .02, LAP-positive cells 
of AT1002-treated versus untreated mice. (D) Weight changes of mice with TNBS-induced colitis 
after intrarectal administration of AT1002. Each point represents the cumulative mean ± SE from 3 
separate experiments. In each experiment, each group consisted of at least 5 mice. *P < .05, 
AT1002-pretreated mice versus untreated mice. (E) Histologic scores of colons of groups of mice 
killed at day 3 after TNBS administration; see scoring criteria in Materials and Methods. 
 
Figure 6. Effect of depletion of commensal microflora. (A) Weight changes after 50% ethanol 
administration. Each point represents the cumulative mean weights ± SE from 2 different 
experiments; in each experiment, each group consisted of at least 5 mice. *P = .04, 50% ethanol 
versus antibiotics/50% ethanol. (B) CD25 and LAP expression in LPMCs 3 days after intrarectal 
ethanol administration from mice that were administered antibiotics (open bars) or untreated mice 
(closed bars). LAP expression in LPMCs of untreated naive mice (grey bars). Data indicate the 
mean percentage of positive cells in the CD3+CD4+ gated population. (C) Weight changes of 
groups of mice recipients of LPMCs obtained from mice treated with ethanol (open triangles), 
recipients of LPMCs obtained from mice treated with antibiotics/ethanol (closed triangles), and 
mice treated with TNBS alone (x). Recipient mice were administered TNBS per rectum 5 days after 
adoptive transfer of LPMCs. Each experimental group consisted of at least 5 mice, and each data 
point represents the mean value ± SE for each group. 
 
Figure 7. Percentages of LAP-positive cells in purified LP CD4+ T-cell populations following 
coculture for 48 hours with CD11c+ dendritic cells isolated from the LP of mice administered 50% 
ethanol or untreated mice. 
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Figure 8. Effect of administration of siRNA specific for TLR2 on ethanol induction of LAP-
positive cells. (A) Western blot analysis of TLR2 and TLR4 expression in untreated mice (lane 1), 
mice administered 50% ethanol (lane 2), mice administered 50% ethanol that received concomitant 
control siRNA (lane 3), or mice administered 50% ethanol that received concomitant siRNA for 
TLR2 (lane 4). (B) Weight changes of groups of mice after administration of siRNA to TLR2 or 
control siRNA to mice pretreated with 50% ethanol. Each point represents the cumulative mean 
weight ± SE from groups consisting of at least 5 mice. *P < .05, siRNA TLR2/50% ethanol versus 
50% ethanol. (C) LAP expression in LPMCs isolated 4 days after intrarectal ethanol administration 
of mice administered concomitant TLR2 siRNA or control siRNA. Data indicate the mean ± SE 
percentage of positive cells in the CD3+CD4+ gated population. (D) In vitro IFN-γ and IL-10 
production by LPMCs isolated from the colons of mice 4 days after ethanol concomitant siRNA 
administration and cultured in the presence of anti-CD3/CD28. Data represent the mean ± SE from 
2 separate experiments comprising data from cultures of pooled cells extracted from 5 mice per 
group. (E) Weight changes of groups of mice after TNBS administration. Each point represents the 
cumulative mean weight ± SE from 2 separate experiments in which each group consisted of at 
least 5 mice. *P < .05, siRNA TLR2/50% ethanol/TNBS versus 50% ethanol/TNBS. (F) 
Photomicrograph (original magnification x50) of an H&E-stained paraffin section of a 
representative colon from each group after induction of TNBS colitis. 
 
Supplementary Figure Legends 
 
Supplementary Figure 1. Effect of a second intrarectal administration of 50% ethanol on regulatory 
T-cell development. To determine the effects of a second intrarectal administration of 50% ethanol, 
mice were administered 50% ethanol 12 days after the first administration. (A) Weight changes of 
untreated mice (open bars) and mice administered ethanol a second time (closed bars). Each point 
represents the cumulative mean weight ± SE from 5 separate experiments in which each group 
contained at least 5 mice; *P < .05 for mice that received a second 50% ethanol administration 
versus untreated mice. The mice receiving a second administration of ethanol exhibited weight loss 
compared with untreated mice; however, in this case, they returned more quickly to their original 
weight than after a single administration of ethanol. (B) In vitro IFN-γ and IL-10 production by 
LPMCs isolated from the colons of mice that received a second administration of ethanol versus 
untreated mice. Data represent means from 4 separate experiments; in each experiment, cultures 
consisted of pooled cells extracted from 5 mice per group. LPMCs extracted from mice 3 days after 
a second administration of 50% ethanol (closed bars) exhibited increased IFN-γ and IL-10 
production, but these increases were not as great as after an initial administration of ethanol. (C) 
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Percentage of CD4+CD25+ T cells and CD4+ LAP-positive T cells in the CD3+CD4+ gated LPMC 
population. CD4+CD25+ T cells and CD4+ LAP-positive T cells were increased compared with 
these cells in LPMCs from untreated mice, but there was no difference between these values and 
those obtained after a single administration of ethanol. 
 
Supplementary Figure 2. Phenotypic characterization of LAP and Foxp3 in CD3+CD4+ gated T 
cells of untreated or ethanol-treated mice. LP cells isolated from untreated and ethanol-treated mice 
were stained with LAP and Foxp3-specific antibodies and analyzed by fluorescence-activated cell 
sorting. 
 
Supplementary Figure 3. Duration of protective effect of ethanol administration. Different groups 
of mice were administered TNBS intrarectally on day 12, 24, and 36 after intrarectal administration 
of 50% ethanol (closed circles) or phosphate-buffered (open circles). Groups of mice consisted of 
at least 5 mice. 
 
Supplementary Figure 4. Effects of intrarectal administration of 50% ethanol are not strain specific. 
(A) Weight curves of ethanol-treated and untreated C57BL10 mice. Each point represents the 
cumulative mean weight ± SE, each consisting of groups of 10 mice. *P < .05, ethanol-treated 
mice versus untreated mice. (B) Effect of a single intrarectal administration of 50% ethanol on the 
generation of CD3+CD4+ LP T cells expressing LAP. Mice were killed at day 3 after treatment. 
Data indicate the percentage of positive cells in the CD3+CD4+ gated population. (C) Effect of 
intrarectal administration of 50% ethanol on induction of TNBS colitis. Weight changes of mouse 
groups after TNBS administration. Each point represents the cumulative mean weight (±SE). In 
each experiment, each group consisted of at least 5 mice. *P < .05, 50% ethanol-pretreated mice 
versus untreated mice. 
 
Supplementary Figure 5. The effect of administration of 50% ethanol on resistance to TNBS-
induced colitis is IL-10 dependent. Weight curves of ethanol-treated and untreated wild-type (WT) 
C57BL10 or C57BL10 IL-10 KO mice after TNBS administration. Each point represents the 
cumulative mean weight (±SE) of at least 5 mice per group. Mice were killed at 3 days after TNBS 
administration. 
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Supplementary Figure 6. Depletion of LAP-positive cells from donor LPMCs or purified LP CD4+ 
T cells of ethanol-pretreated mice before adoptive cell transfer abolishes the protective effect. (A) 
Histology of (a) groups of mouse recipients of LPMCs obtained from mice treated with ethanol, (b) 
recipients of LAP-positive cell-depleted LPMCs obtained from mice treated with ethanol, (c) 
recipients of LPMCs obtained from mice treated with TNBS, and (d) mice treated with TNBS 
alone. Recipient mice were administered TNBS per rectum 5 days after adoptive transfer of 
LPMCs. Recipients of LPMC cells from LAP-depleted or TNBS-induced colitis mice did not differ 
in severity compared with mice treated with TNBS alone; recipients of LPMCs from ethanol-
treated mice revealed only minimal inflammatory changes. (B) Histology of (a) groups of mouse 
recipients of LPMCs obtained from mice treated with ethanol, (b) recipients of purified LP CD4+ T 
cells obtained from mice treated with ethanol, (c) recipients of LAP-positive cell-depleted LP CD4+ 
T cells obtained from mice treated with ethanol, and (d) mice treated with TNBS alone. Recipient 
mice were administered TNBS per rectum 5 days after adoptive transfer of LPMCs. Recipients of 
LP CD4+ T cells from LAP-depleted ethanol-treated mice did not differ in severity compared with 
mice treated with TNBS alone; recipients of LPMCs or purified LP CD4+ T cells from ethanol-
treated mice revealed only minimal inflammatory changes. 
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Abstract 
Based on previous studies demonstrating that a breach of the colonic epithelial barrier is associated 
with a microbiota-dependent increase in LP regulatory cells, we investigated if the lack of 
spontaneous intestinal inflammation observed in Nod2-/- mice was due to enhanced intestinal 
regulatory function.  We found that the LP CD4+ T cell population of Nod2-/- mice contains an 
increased percentage of CD4+ regulatory T cells bearing TGF-β/latency peptide (LP CD4+LAP+ T 
cells) both under baseline conditions and following an intentional breach of the colonic barrier 
induced by ethanol administration.  In addition, we found that Nod2-/- mice manifest decreased 
severity of TNBS-colitis and that TNBS-colitis in Nod2-/- or Nod2+/+ mice is ameliorated by 
adoptive transfer of LP cells from ethanol-treated mice before, but not after, depletion of LAP+ T 
cells. This increased regulatory T cell response in Nod2-/- mice could explain why NOD2 
polymorphisms in humans are not in themselves sufficient to establish inflammatory lesions.  
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Introduction 
NOD2 (nucleotide-binding oligomerization domain 2) is a member of the NLR (NOD, leucine-rich 
repeat (LRR)-containing protein) family of intracellular microbial sensors that has gained 
prominence because polymorphisms in the CARD15 gene encoding this protein is the single most 
important genetic risk factor in Crohn’s disease (1-4). The NOD2 LRR sensor recognizes muramyl 
dipeptide (MDP), a component of the peptidoglycan present in the bacterial cell wall and thus 
NOD2 is likely to be an innate immune factor that participates in the control of organisms that 
enter the lamina propria.  This has led to the view that abnormal Nod2 function associated with 
LRR polymorphisms  leads to blunted clearance of such organisms and thus an inflammatory 
response mediated by innate immune functions unrelated to Nod2 (5, 6). However, another view is 
based on evidence that Nod2 is a negative regulator of TLR signaling and its deficiency results in 
enhanced production of Th1 polarizing cytokines in the TLR-rich gut micro-environment (7).  Mice 
with Nod2 deficiency have characteristics that bear on this question. For instance it has been shown 
that Nod2-/- mice exhibit increased CD4+ T cell IFN-γ production that is dependent on the 
presence of the intestinal microbiota and this, in turn, leads to increased bacterial translocation into 
the Peyer’s patches (PP) and increased PP epithelial permeability due to induction of myosin light 
chain kinase, a factor that down-regulates tight junction integrity. Furthermore, such T cell-
epithelial cell cross-talk under the control of TLR signaling, which is increased in Nod2-/- mice, 
but can be down-regulated in Nod2+/+ mice by administration of MDP (Nod2 ligand).  Thus it 
appears that bacterial translocation in Nod2-/- mice results from an absence of Nod2 regulation of 
TLR function (8, 9).  These findings favor the second hypothesis relating to polymorphic NOD2 in 
Crohn’s disease, namely that the latter leads to hyper-responsiveness (10).  
Despite the above mentioned permeability changes, Nod2-/- mice do not develop overt intestinal 
inflammation, suggesting that Nod2 abnormalities are not sufficient to cause spontaneous and full-
blown inflammatory lesions in themselves.  Possibly relating to this, we previously demonstrated 
that a transient breach of the colonic epithelial barrier and an associated transient increase in the 
intestinal permeability is characterized by a microbiota-dependent increase in the generation of 
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regulatory cytokines and cells.  In particular, such breaches were associated with the expansion 
Foxp3-negative CD4+ T cells expressing surface TGF-β associated with the latency associated 
peptide (LAP) (CD4+LAP+ T cells) that render mice resistant to the induction of 2,4,6-
trinitrobenzene sulfonic acid (TNBS)-induced colitis (11). Thus, the lack of spontaneous 
inflammation in mice with Nod2 deficiency may be due to an enhanced mucosal regulatory 
response. To explore this hypothesis we investigated the mucosal regulatory response of mice with 
Nod2 deficiency following a breach of the colonic barrier. We found that the lamina propria of 
Nod2-/- mice, when compared to Nod2+/+ (WT) mice, contains an increased percentage CD4+ T 
cells that are CD4+LAP+ regulatory T cells; furthermore, we found using cell transfer studies that 
these regulatory cells are likely to be responsible for the decreased severity  of TNBS-colitis 
observable in  Nod2-/- mice . Thus, an increased regulatory T cell response to microbiota  in Nod2-
/- mice could indeed explain why NOD2 polymorphisms in humans are not sufficient to establish 
inflammatory lesions in the absence of other abnormalities. 
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Results 
 Nod2-/- mice exhibit increased colonic permeability associated with an expanded subpopulation of 
LP CD4+LAP+ T cells.  
Since it has been reported that Nod2-/- mice show increased PP permeability and bacterial 
translocation (8), in initial studies we assessed colonic permeability and in vivo cytokine production 
in untreated Nod2-/- mice. As shown in Figure 1, we found that Nod2-/- mice exhibit a significant 
increase in baseline colonic permeability when compared with Nod2+/+ mice as measured by 
uptake of intra-rectal FITC-dextran into the serum.  Moreover, as also shown in Figure 1, this 
permeability change was associated with a significant increase in in vivo IL-12p70 production as 
measured by LP tissue content of this cytokine (as well as TNF-α, data not shown), suggesting that 
the permeability change had led to increased stimulation of LP macrophages and/or dendritic cells 
by innate stimuli derived from the intestinal microbiota.  One might predict that this increased IL-
12p70 production would be accompanied by increased LP T cell IFN-γ production, but, as shown 
in Figure 1, in vivo IFN-γ production in Nod2-/- mice was not increased as assessed by 
measurement of tissue content of this cytokine. It should be noted, however, that Nod2-/- LP T 
cells showed some evidence of enhanced Th1 differentiation in that stimulation of purified LPMC 
with anti-CD3/CD28 exhibited a significant increase in IFN-γ production in vitro.  
 
To examine if the above lack of IFN-γ production in vivo could be due to down-regulation of LP T 
cell production of this cytokine we next determined if the Nod2-/- lamina propria contained 
increased regulatory factors.  As shown in Figure 1, panel E  flow cytometric studies revealed that 
Nod2-/- lamina propria CD4+ T cells populations contained a significantly increased percentage of 
LP CD4+LAP+ T cells and, moreover, Nod2-/- mice lamina propria exhibited a significant increase 
in tissue content of TGF-β, as compared to cells and tissues respectively from Nod2+/+ mice 
(Figure 1, panel F).  However, we did not observe an increase in the percentage of CD4+ Foxp3+ T 
cells within the LP CD4+ T cell population (Nod2-/-: 11.33 %± 1.42 vs. Nod2+/+: 10.68%±0.71; 
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mean± SE ; p=0.65). The above findings thus provide initial support for the possibility that the lack 
of increased IFN-γ secretion in vivo in Nod2-/- mice is in fact due to down-regulation of pro-
inflammatory T cell differentiation by regulatory cells that do not express Foxp3. 
 
Enhanced expression of CD4+LAP+ T Cells in Nod2-/- mice is dependent on an intact intestinal 
microbiota.  
In previous studies it was shown that the intestinal microbiota acting through myosin light chain 
kinase (MLCK)-mediated effects on epithelial tight junctions was responsible for changes in the 
permeability of the Peyer’s patch epithelium in Nod2-/- mice (9).  We reasoned that a similar 
mechanism may obtain with respect to the increased numbers of LP CD4+LAP+ T cells observed 
in Nod2-/- mice inasmuch as we have shown previously that induction of increased numbers of the 
latter cells in WT mice is also dependent on the presence of an intact intestinal microbiota (11).  In 
initial studies to examine this question we treated mice with ampicillin for 3 weeks and evaluated 
the frequency of LP CD4+LAP+ T cells in the treated mice (as well as in the untreated control 
mice). As shown in Figure 2, panel A, while ampicillin administration to Nod2+/+ mice did not 
significantly affect the percentage of LP CD4+LAP+ T cells, administration to Nod2-/- mice was 
associated with a significant reduction of the percentage of LP CD4+LAP+ cells and at the end of 
the treatment period LP CD4+LAP+ levels in Nod2-/- mice were comparable to those in Nod2+/+ 
mice. Thus, the increased numbers of LP CD4+LAP+ T cells in Nod2-/- mice is dependent on the 
presence of an intact intestinal microbiota. 
 
With this information in hand, we next turned our attention to role of MLCK in the expansion of 
LP CD4+LAP+ T cells in Nod2-/- mice.  To this end, we determined LP CD4+LAP+ T cell levels 
in Nod2-/- and Nod2+/+ in mice pre-treated  with an agent, ML-7, that has been shown to block 
the kinase activity of MLCK and thus inhibit its effect on intestinal permeability (9).  In initial 
studies shown in Figure 2, panel B, we first verifi
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administration led to a reduction in serum concentration of intrarectally administered FITC-dextran  
in both Nod2-/- and Nod2+/+ mice. Then, as shown in Figure 2, panel C, we showed that ML-7 
administration led  to a statistically significant   reduction in the number of   LP CD4+LAP+ T cells 
in Nod2-/- mice that was now not statistically different from that in Nod2+/+mice. Taken together, 
these studies suggest that an intact intestinal microbiota is necessary for the induction of increased 
LP CD4+LAP+ T cells in Nod2-/- mice and that such induction acts, at least in part, via MLCK 
effects on intestinal permeability. 
 
The role of CD11c+ dendritic cells in LP CD4+LAP+ T cell  expansion in Nod2-/- mice. 
In previous studies we showed that CD11c+ dendritic cells (DCs) from ethanol-treated mice 
induced a greater increase in LP CD4+LAP+ T cells among co-cultured CD4+ T cells than an 
identical population of dendritic cells from untreated mice.  This, taken with the observation that 
suppression of in vivo TLR2 responses by TLR2 siRNA administration had a down-regulatory 
effect on induction of LP CD4+LAP+ T cells, suggested that TLR-stimulated CD11c+ DCs were 
driving LP CD4+LAP+ T cell expansion (11).  Applying this information to a further examination of 
the role of CD11c+ DCs in the increased of LP CD4+LAP+ T cells in Nod2-/- mice, we co-
cultured purified lamina propria CD11c+ cells from Nod2-/- and Nod2+/+ with   isolated LP CD4+ 
cells from  Nod2-/- and Nod2+/+ mice (at a 1:2 ratio) in various combinations and then assessed 
LAP+ expression after 48 h of culture. As shown in Figure 3, panel A, co-culture of CD11c+ DCs 
with CD4+ T cells from Nod2-/- mice, was associated with a larger increase in LAP+ T cells as 
compared to the increase in LAP+ T cells in co-cultures of CD11c+ DCs  and  CD4+T cells from  
Nod2+/+ mice. Furthermore, increases seen in co-cultures of CD11c+ DCs from Nod2-/- mice and 
CD4+ T cells were equal regardless of the source of CD4+ T cells. These data thus suggest that 
DCs from Nod2-/- mice are more efficient in inducing the expansion of LAP+ T cells as compared 
to DCs from Nod2+/+ mice.   
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In previous studies we also showed  that TLR2 stimulation was responsible for the increased in LP 
CD4+LAP+ cell level observed after ethanol-induced increase of epithelial permeability(11).   We  
performed co-culture experiments in the presence of the TLR2 stimulant Pam3CSK4 to further 
investigate the role of lamina propria dendritic cells in LP CD4+LAP+ cell expression.  As shown 
in Figure 3, panel B, TLR2 stimulation of CD11c cells from Nod2-/- mice co-cultured with CD4+ 
cells from either Nod2-/- or Nod2+/+ mice did not increase the percentage of LP CD4+LAP+ cells 
over the already increased percentage observed in unstimulated co-cultures. In contrast, TLR2 
stimulation of CD11c cells from Nod2+/+ mice co-cultured with CD4+ cells from Nod2-/- or 
Nod2+/+ mice led to an increase in the percentage of LP CD4+LAP+ cells over the relatively low 
percentage observed in unstimulated co-cultures in two experiments.  
Thus, CD11c dendritic cells not subjected to “in vitro” TLR2 stimulation from Nod2-/- mice are as 
efficient in inducing the expansion of LP CD4+LAP+ T cells due to sustained “in vivo” TLR2 
stimulation as CD11c cells subjected to “in vitro” TLR2 stimulation from Nod2+/+ mice. In view 
of the dependence of LP CD4+LAP+ T cells on the intestinal microbiota, these data also suggest 
that dendritic cells stimulated   by TLR ligands in the intestinal microbiota are driving the increase 
in the number of these cells in the lamina propria of Nod2-/- mice. 
 
Nod2-/- mice mount an enhanced regulatory T cell response and exhibit less inflammation upon 
challenge with i.r. ethanol.  
In a previous study we showed that the number of LP CD4+LAP+ T cells in the colonic mucosa 
was augmented by administration of an agent, such as ethanol, that increases the permeability of 
the mucosal epithelial barrier. This and the fact that Nod2-/- mice display increased baseline 
mucosal permeability prompted us to explore further the lack of inflammation in the lamina propria 
of Nod2-/- mice and its possible relation to the presence of increased numbers of LP CD4+LAP+ 
regulatory T cells.  To this end, we conducted studies in which Nod2-/- mice are subjected to 
intentional induction of increased mucosal permeability by ethanol administration.  As shown in 
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Figure 4, panel A, intrarectal (i.r.) ethanol administration caused a transient increase in colonic 
permeability in both Nod2-/- and Nod2+/+ mice. As shown in Figure 4, panel B, despite such 
increased permeability, Nod2-/- mice displayed significantly less weight loss as compared to 
Nod2+/+ mice and, as shown in Figure 4, panel C,  Nod2-/- mice exhibited little or no intestinal 
inflammation (colitis score: 0), whereas  Nod2+/+ mice exhibited mild intestinal inflammation 
(colitis score: 1-2).  In vivo IL-12p70 and IFN-γ responses to ethanol administration provided 
parallel results; thus, as shown in Figure 4, panels D, while baseline IL-12p70 production was 
higher in Nod2-/- mice than in Nod2+/+ mice, the latter mice exhibited a sharp rise in in vivo IL-
12p70 production that led to a production level that exceeded that of  Nod2-/- mice on the day of 
maximal permeability change, while Nod2-/- mice did not show any significant change in IL-12p70 
tissue content after ethanol administration. As shown in Figure 4, panel E, a similar picture was 
observed  for in vivo IFN-γ production although in this case baseline production of this cytokine 
were essentially the same in Nod2-/- and  Nod2+/+ mice. Corroborative results were obtained 
when we administered a second dose of 50% ethanol to the mice on day 4. Thus, as shown in 
Supplementary Figure 1, such secondary ethanol administration was again associated with less 
weight loss in Nod2-/- as compared to Nod2+/+ mice. 
 
The above difference between Nod2-/- and Nod2+/+ mice in their response to i.r. ethanol 
administration could be the result from the fact that Nod2-/- mice mount a greater regulatory 
response. As shown in Figure 5, panel A and Supplementary Figure 2, evidence that this was 
indeed the case came from studies showing that Nod2-/- mice exhibited a greater increase in the 
percentage of LP CD4+LAP+ T cells among CD4+ LPMCs on the day of maximal permeability 
change and the relatively weak LP CD4+LAP+ T cell response of Nod2+/+ mice was delayed. In 
both cases, however,  the  percentage of LP CD4+LAP+ T cells at day 3 did not differ from  
baseline levels of the untreated mice.   Finally, as shown in Figure 5, panel B, Nod2-/- mice also 
mounted an earlier and higher in vivo TGF-β production response than   Nod2+/+ mice following 
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i.r. ethanol administration, although responses in both groups of mice were increased under these 
circumstances. 
 
As previously reported (11), and as shown in the flow cytometric study depicted in Supplementary 
Figure 2, the majority of LP CD4+LAP+ T cells on day one after ethanol challenge were Foxp3-
negative.  However, as also shown in this figure, the percentage of LP CD4+LAP+Foxp3+ T cells  
among LPMC’s also increased after ethanol administration at this time point. In addition, this 
increase was particularly evident 2-3 days after ethanol challenge: (Nod2-/- baseline: 11.71% ±0.74 
vs. Nod2-/- day3: 16.27%±2.04 mean± SE p=0.01;  Nod2+/+ baseline: 9.93%±1.18 vs. day 
2:16.03%±2.85 mean± SE p=0.02).  Importantly, however, the increase in Foxp3+ T cells was 
equivalent in Nod2-/- and Nod2+/+ mice, indicating that this did not explain the differences in 
degree of ethanol-induced inflammation and cytokine response between these groups.  
 
The expansion of LP CD4+LAP+ T cells results in decreased severity of TNBS-colitis in Nod2-/- 
compared to Nod2+/+ mice. 
To obtain further evidence that the increased percentage of LP CD4+LAP+ T cells of Nod2-/- mice 
before or after ethanol treatment is preventing the development of colitis in Nod2-/- mice we next 
conducted studies to determine if these cells affected the induction of TNBS-colitis, a colitis known 
to be modulated by LP CD4+LAP+ T cells and TGF-β (12).  To ensure valid results we conducted 
studies in Nod2-/- mice and control Nod2+/+ mice that had been re-derived by embryo transfer 
into littermate foster mothers raised in the same SPF animal facility and in the same cage and then 
placed in separate cages prior to birth; thus, the mice had a similar origin and were reared in the 
same facility. 
 
  
63
As shown in Figure 6, panels A and B, Nod2-/- mice administered intra-rectal TNBS (in 50% 
ethanol) to induce TNBS-colitis developed less severe colitis than Nod2+/+ mice as shown by their 
lower weight loss and degree of colonic inflammation. In addition, as shown in Figure 6, analysis 
of anti-CD3/CD28-induced LPMC cytokine production in vitro showed that while IFN-γ 
production by LPMCs from Nod2-/- mice was significantly higher than that of LPMCs from 
Nod2+/+ mice, IL-17 production by LPMCs from Nod2-/- mice was significantly lower than that 
of LPMCs from Nod2+/+ mice and was equivalent to baseline (ethanol alone) IL-17 production.  
Taken together, these studies as well additional studies described below offer strong evidence that 
Nod2-/- mice, as compared to Nod2+/+ mice, are resistant to induction of an induced colitis, 
TNBS-colitis. 
 
To determine if the decreased severity of TNBS-colitis in Nod2-/- mice was attributable to the 
induction of LP CD4+LAP+ T cells we took advantage of our previous findings showing that 
LPMCs from mice treated with ethanol and thus with expanded LP CD4+LAP+ T cell populations 
can protect mice from TNBS-colitis upon adoptive transfer to the latter when cells are transferred 
before but not after depletion of LAP+ T cells (11). In studies along these lines, we assessed the 
severity of TNBS-colitis in Nod2-/- and Nod2+/+ mice after adoptive transfer of LPMC from  
Nod2-/- and  Nod2+/+ mice (respectively) that had been treated with ethanol (50%) one day prior 
to cell harvest and transfer. As shown in Figure 7, panels A-D, recipients of LPMC from ethanol-
treated mice exhibited amelioration of colitis as assessed by weight loss and histological evaluation 
of colonic inflammation; however, the level of amelioration was greater in Nod2-/- recipients than 
in Nod2+/+ recipients possibly due to the fact that ethanol-treated LPMC from Nod2-/- donors 
contains a higher level of LAP+ T cells.  In contrast, as also shown in Figure 7, panels A-D, Nod2-
/- recipients of LPMCs from ethanol-treated mice that had be subjected to LAP+ T cell depletion 
(See Methods) exhibited more severe colitis than mice treated with TNBS alone and equivalent to 
that observed in Nod2+/+ treated with TNBS alone.  Thus, the transferred LP CD4+LAP+ T cell 
depleted cell population derived from ethanol-treated mice contains cells that act as potent pro-
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inflammatory T cells in the TNBS-treated recipient mice (see further studies of cytokine production 
by these cells below).  Finally, Nod2+/+ recipients of LPMCs from ethanol-treated mice that had 
been subjected to LAP+ T cell depletion exhibited the same level of colitis as mice treated with 
TNBS alone. 
 
As shown in Figure 7, panels E-H, analysis of anti-CD3/CD28-induced in vitro cytokine 
production, by equivalent numbers of cell per culture, revealed that amelioration of TNBS-colitis 
observed in  Nod2-/- and Nod2+/+ recipients of LPMC (whether or not depleted of LAP+T cells) 
from ethanol-treated mice was not associated with changes in IFN-γ production.  However, in both 
recipient groups, whereas transfer of undepleted LPMC was associated with non-significant 
reductions in IL-17 production, transfer of depleted LPMC was associated with significant 
increases in IL-17 production.  These data thus indicate that increased severity of TNBS-colitis in 
recipients of LPMC depleted of LAP+ T cells correlates best with levels of IL-17 production per 
cell. 
 
In complementary studies we performed adoptive transfer studies in which Nod2+/+ mice with 
TNBS-colitis were transferred LPMCs from ethanol-treated Nod2-/- mice rather than Nod2+/+ as 
in the experiments described above.  As shown in Figure 8, transfer of LPMCs from Nod2-/- mice,  
was associated with amelioration of colitis, but in this case the level of amelioration was somewhat 
greater than with transfer of LPMCs from Nod2+/+ mice. This is in keeping with the fact that 
ethanol treatment of Nod2-/- mice led to the generation of a greater number of LP CD4+LAP+ T 
cells than ethanol treatment of Nod2-/- mice (Figure 5) and that Nod2+/+ mice recipient of Nod2-/- 
LAP- depleted LPMC show a TNBS colitis course comparable to the Nod2+/+ mice treated with 
TNBS alone. 
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Overall, then, these adoptive transfer studies of TNBS-colitis are compatible with the view that the 
LP CD4+LAP+ T cell subpopulation generated by ethanol administration in Nod2-/- mice is 
capable of suppressing TNBS-colitis in both Nod2-/- and Nod2+/+ mice and this suppression is 
greater than that obtained with a LP CD4+LAP+ T cell subpopulation generated by ethanol 
administration in Nod2+/+ mice.   
 
Influence of the endogenous Intestinal Microbiota on TNBS-Colitis in Nod2-/- Mice: co-housing 
studies  
In studies described above it was shown that the generation of LP CD4+LAP+ regulatory cells was 
dependent on the presence of an intact intestinal microbiota.  Thus, it seemed possible that Nod2-/- 
mice harbor a changed microbiota that affects the development of regulatory cells in the Nod2-
deficient host.  To examine this possibility we conducted co-housing studies in which Nod2-/- mice 
were maintained in the same cages with Nod2+/+ mice or maintained in separate cages at weaning 
for four weeks before induction of TNBS-colitis.  As shown in Figure 9, co-housed Nod2-/- mice 
exhibited more severe colitis and decreased LP CD4+LAP+ T cells than non-co-housed  Nod2-/- 
mice.  Reciprocal studies of Nod2+/+ showed that Nod2+/+ mice did not exhibit a change in 
baseline LP CD4+LAP+ cells (not shown).  Thus, the Nod2-/- mice develop an intestinal 
microbiota that supports regulatory responses that contribute to the protection of mice from 
development of TNBS-colitis 
 
Dextran sulfate sodium (DSS) colitis in Nod2-/- mice. 
 
To determine if Nod2-deficient mice are protected from additional forms of experimental colitis we 
also assessed the severity of DSS-colitis in Nod2-/- and Nod2+/+ mice. The mechanism of 
inflammation in DSS-colitis differs from that in TNBS-colitis in that it is dominated by a toxic 
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effect of DSS on epithelial cells followed by massive stimulation of innate cells (macrophages) by 
commensal gut bacteria and activation of the NLRP3 inflammasome (13); thus, this colitis is less 
dependent on a T cell response as is TNBS-colitis. As shown in Supplementary Figure 3, in 
agreement with previous reports (14, 15), we observed that administration of low concentrations of 
DSS in drinking water led to more severe colitis in Nod2-/- mice than in Nod2+/+ mice as shown 
by weight loss, myeloperoxidase activity and histology (the latter not shown).  It was thus apparent 
that colitis dependent mainly on innate cell activation is under less regulation by LP CD4+LAP+ T 
cells than is colitis dependent mainly on T cells. 
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Discussion 
In the present study we investigated the factors accounting for the observation that mice with Nod2 
deficiency do not exhibit significant spontaneous colonic inflammation despite the well-established 
role of NOD2 polymorphisms as risk factors in Crohn’s disease. We found that Nod2-/- mice 
manifest increased colonic permeability and heightened LP IL-12p70 production associated with 
little or no change in downstream LP IFN-γ production.  The latter suggested the presence of a 
regulatory response and indeed the LP of Nod2-/- mice contained an increased subpopulation of 
LAP+ regulatory T cells among the lamina propria CD4+ cells that in subsequent studies was 
shown to be accentuated by intra-rectal ethanol administration and an accompanying increase 
mucosal permeability. We then showed that Nod2-/- mice are resistant to the development of 
TNBS-colitis and that such resistance is likely due to the presence of the LP CD4+LAP+ T cells.  
In particular, we found that adoptive transfer of LP T cells from ethanol-treated mice enhanced 
protection from TNBS-colitis whereas transfer of these cells following depletion of LAP+ T cells 
not only abolished such protection, it led to a level of colitis observed in Nod2+/+ mice.  Finally, 
we found that Nod2-/- mice develop a microbiota that favors the development of LP CD4+LAP+ 
regulatory cells and thus contributes to protection from induction of TNBS-colitis. These 
observations provide a strong rationale for why Nod2 deficiency does not itself lead to overt 
intestinal inflammation as well as why humans with NOD2 abnormalities require the presence of 
additional factors to manifest Crohn’s disease. 
Previous studies have provided evidence both in mice with Nod2 deficiency and in humans with 
NOD2 polymorphisms associated with Crohn’s disease that NOD2 in myeloid cells functions as a 
negative regulator of TLR signaling and that such lack of “cross-regulation” of innate immune 
responses is a major reason why NOD2 abnormalities may underlie the excessive mucosal immune 
responses that lead to Crohn’s disease (7-9, 16). In one of these previous studies as well as in the 
present study this consequence of Nod2-deficiency could also explain the fact that Nod2-/- mice 
exhibit high baseline (sub-inflammatory) mucosal cytokine production and increased activity of 
myosin light chain kinase, a factor that is the likely cause of the increased gut permeability in these 
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mice due to its effects on tight junctions.  In addition, it could explain the dependence of these 
various abnormalities on the presence of the intestinal microbiota, the source of mucosal TLR 
responses and the increased capacity of lamina propria CD11c+ DCs from Nod2-/- mice to induce 
LP CD4+LAP+ T cells compared to similar DCs from Nod2+/+ mice.  On this basis the following 
sequence of events is a likely explanation for the increased LAP+ T cells response in Nod2-/- mice: 
1) intestinal microbiota (via TLR stimulation) induce lamina propria DCs in Nod2-/- mice to 
produce sub-inflammatory amounts of cytokines that stimulate activation of MLCK; 2) MLCK 
causes increased intestinal permeability and further exposure of lamina propria DCs to microbiota 
TLR stimulation; 3) the DCs so-activated induce LP CD4+LAP+ regulatory cells. An additional 
factor bearing on the development of regulatory cells in Nod2-/- mice is that, as discussed in 
greater detail below, the Nod2 deficiency in Nod2-/- mice leads to the development of an intestinal 
microbiota with an increased capacity to induce the development of regulatory cells.  Thus, the 
effects of Nod2 deficiency on intestinal  permeability is abetted by its effects on the intestinal 
microbiota. 
The above analysis of the generation of regulatory cells in Nod2-deficient mice is compatible with 
the somewhat unexpected view that the consequences of Nod2 dysfunction are two-fold. On the 
one hand, it leads to a tendency to mount increased TLR-induced responses that favor the 
development of inflammation and thus explain its role as a risk factor for Crohn’s disease. On the 
other hand, as shown in these studies, it also leads to an increased TLR-induced regulatory 
response that establishes a resistance to inflammation. Which of these tendencies prevail is likely to 
depend on the nature, strength and persistence of the inflammatory stimulus.  When the stimulus is 
relatively weak and self-limited as in the present study of TNBS-colitis in C57BL/6 mice the 
regulatory response prevails and one sees protection from colitis; in contrast, when, in the same 
mice, the stimulus is strong as in DSS-colitis and accompanied by massive breakdown of the 
epithelial barrier leading to invasion of the mucosa by commensal organisms, the inflammatory 
response prevails and one sees more inflammation. These different inflammatory conditions might 
model different environmental triggers of Crohn’s disease and thus explain disease initiation and 
recrudescence in patients with NOD2 abnormalities. 
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LP CD4+LAP+ T cells are a unique regulatory cell population characterized by the presence of cell 
surface (LAP-associated) TGF-β and the absence of Foxp3 expression. As suggested by our 
previous observations in both mice and humans, this cell population tends to have a mucosal 
location and a size that is largely influenced by the prevailing microbiota (11, 12, 17). Thus, we showed 
in a murine model of experimental colitis (12) and in humans with ileal-pouch-anal anastomosis for 
ulcerative colitis (17), that oral administration of a mixture of probiotics was able to expand lamina 
propria CD4+LAP+ T cells, while treatment of mice with oral antibiotics prevents their expansion 
(11)
. The regulatory activity of LP CD4+LAP+ T cells has been highlighted in studies showing that 
they ameliorate colitis in both the cell transfer (18) and TNBS-colitis models (11, 12) and has, in 
addition, been recently confirmed in a model of murine asthmatic lung inflammation (19). Finally, 
the regulatory activity of peripheral CD4+LAP+ T cells (possibly derived from the mucosal 
surface) has also been recently shown in humans (20). The results of these various studies of LP 
CD4+LAP+ T cells, taken in conjunction with those in the present study, establish that this cell 
population has an important role in maintaining immune homeostasis in the microbiota-rich 
environments of the mucosal surfaces. 
 In the present study we observed a selective expansion of CD4+LAP+Foxp3- T cells in Nod2-/- 
mice as compared to Nod2+/+ T cells but no comparable expansion of the CD4+Foxp3+ cell 
population. However, the latter population did expand equally in Nod2-/- and Nod2+/+ mice in 
response to a transient increase in intestinal permeability induced by intra-rectal ethanol 
administration.  These results emphasize that CD4+Foxp3+ cells are distinct from CD4+LAP+ T 
cell population in this context and do not underlie the intestinal regulatory response associated with 
Nod2 deficiency.  Nevertheless, these two cell populations are likely to be related on some level 
given the fact that membrane-bound TGF-β bound to LAP is present on both types of cells and, as 
such, is likely to be involved in their respective suppressive activities (21).  In addition, it has 
recently been shown that Foxp3 induces surface TGF-β/LAP expression and that TGF-β induces 
TGF-β/LAP expression in Foxp3- cells (22). This, plus the well known fact that TGF-β induces 
Foxp3, suggests a broad (if as yet incompletely defined) inter-relation between TGF-β, Foxp3 and 
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surface TGF-β/LAP expression. This proposed inter-relationship, however, does not necessarily 
imply that CD4+LAP+Foxp3- T cells and CD4+Foxp3+ cells belong to the same cell lineage or 
share the same set of inductive factors (23). The latter is evident from the present study in that the 
induction of CD4+LAP+Foxp3- cells appears to require special conditions that include the 
presence of high levels of TGF-β as well as dendritic cells producing a possibly unique mixture of 
cytokines resulting from the strong TLR signaling present in the lamina propria in Nod2-/- mice. 
This view is at least partially supported by the observation that the kinetics of LP 
CD4+LAP+Foxp3- T cell expansion observed in our study parallels the kinetics of TGF-β 
production and from previous evidence that the in vivo generation of CD4+ LAP+ Foxp3- cells is 
dependent on both TGF-β and IL-10 (19). 
As indicated above, in the present study we observed that Nod2-/- mice exhibit less severe TNBS-
colitis when compared to Nod2+/+ mice.  This finding correlated with the fact that in adoptive 
transfer studies we showed that LPMC from Nod2-/- mice donor mice had a greater capacity to 
ameliorate colitis than cells from Nod2+/+ donor mice. In addition, we showed that this effect 
reflected the greater number of LP CD4+LAP+ T cells in the Nod2-/- cell population as deletion of 
these cells from the transferred cell population abolished the protective effect of cell transfer.   
Thus, these transfer studies provided a mechanistic basis for the decreased severity of colitis in 
Nod2-/- mice. Somewhat unexpectedly, on a per cell basis, the decreased inflammation of TNBS-
colitis in Nod2-/- mice was associated with decreased LPMC IL-17 and increased IFN-γ production 
as compared to Nod2+/+ mice.  Furthermore, Nod2-/- recipients of adoptively transferred LAP+ T 
cell-depleted LPMC exhibited a cytokine response comparable to that of Nod2+/+ mice that was 
characterized by increased LPMC production of IL-17 but no change in IFN-γ production. These 
data suggesting that IL-17 production plays a more important role in the pathogenesis of TNBS-
colitis than IFN-γ in C57BL/6 mice are in agreement with a previous report wherein it was shown 
that while such colitis was marked by increased in vivo IL-17 and IFN-γ production, less severe 
colitis was observed in IL-17R-deficient mice despite the presence of increased IFN-γ tissue levels 
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(24)
. In addition, the increase in IL-17 production in recipients of CD4+LAP+ -depleted cells 
suggests that the CD4+LAP+ T cells might be acting, in part, via regulation of Th17 cells.  
The decreased severity of TNBS-colitis in Nod2-/- mice observed in our study is in contrast with 
previous studies in which an increased severity of colitis in Nod2-/- mice compared to  Nod2+/+ 
mice was reported (8, 25). This may have been due to differences in the intestinal microbiota acquired 
by mice in the various mouse-housing facilities utilized since it is known that at least IL-17 
production can be influenced by nature of the resident microbiota (26). Thus, it is possible that 
Nod2-deficient mice is various facilities acquire somewhat unique sets of microbiota more or less 
capable of inducing pro-inflammatory effector cells and anti-inflammatory regulatory T cells that 
then serve as environmental stimuli leading to different Nod2-deficiency outcomes as discussed 
above.  Also bearing on this issue are recent studies that have shown that changes in the intestinal 
microbiota are associated with Nod2 deficiency (27, 28).  Indeed, our studies corroborate this finding 
in that we have found in co-housing studies that Nod2-/- mice reared together with Nod2+/+ mice 
post-weaning developed less LP CD4+LAP+ cells and more severe TNBS-colitis than Nod2+/+ 
mice reared independently.  It was thus evident that the microbiota in Nod2-/- mice was distinct 
from that in Nod2+/+ mice in that it had a greater capacity to induce regulatory cells.  This implies 
that the Nod2-deficiency in Nod2-/- mice operates in two ways to favor regulatory cell 
development: 1) it leads to permeability changes that increase exposure of dendritic cells to factors 
such as TLR ligands that induce such development and 2) it creates a milieu that permits changes 
in the microbiota that support such development.  At this point the nature of these latter changes are 
quite undefined although we would speculate that they involve selective expansion of organisms 
similar to previously described inducers of regulatory cells such as members of the Clostridium 
bacterial family (29).  Delineation of this possibility is clearly an area of potentially fruitful future 
work. 
In summary, data from the present study suggest that the increased intestinal permeability observed 
in Nod2-/- mice is associated with an increased homeostatic regulatory response mediated by LP 
CD4+LAP+ T cells.  They thus suggest that factors influencing this regulatory response (or 
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possibly over-riding this response) might be necessary to induce a full-blown inflammation in the 
presence of Nod2 deficiency. This conclusion is relevant to IBD in humans where increased 
intestinal permeability (30, 31) and an altered microbiome (32, 33) have been reported to be associated 
with NOD2 polymorphisms in the absence of inflammation. 
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Materials and Methods 
 
Mice 
Nod2+/+ and Nod2-/- mice on C57BL/6 background were kindly donated by Peter J Murray, 
Department of Infectious Diseases and the Department of Immunology, St. Jude Children's 
Research Hospital, Memphis, Tennessee, USA (34). At the Istituto Superiore di Sanità Nod2-/- mice 
and control Nod2+/+ mice had been re-derived by embryo transfer into littermate foster mothers 
raised in the same SPF animal facility and in the same cage. Nod2-/- and Nod2+/+ mice were then 
maintained in SPF conditions in the animal facility at the Istituto Superiore di Sanità, Roma, Italy. 
All mice were housed with free access to food and water. Pathogen-free conditions were monitored 
every 6 months in accordance with the full set of FELASA high standards recommendations. All 
animal studies were approved by the Animal Care and Use Committee of the Istituto Superiore di 
Sanità. 
 
Study design 
All studies were performed in 7-8 week old male mice. In studies of ethanol effects on regulatory T 
cell expression mice were administered 50% ethanol, via a 3.5 F catheter inserted into the rectum 
as previously described (11); subsequently, mouse weights and histological appearance of the 
colonic tissue was determined at various time points.  In studies on the effects of   myosin light 
chain kinase (MLCK) inhibition, mice were administered intraperitoneal injections ML-7 (2mg/kg; 
Sigma-Aldrich, Milan, Italy), a MLCK inhibitor, twice daily for 4 days (9).  In studies on the effect 
of antibiotic administration, mice were administered ampicillin (Pfizer Italia srl, Latina, Italy) 
200µg/100µl distilled water by oral gavage for 14-21 days; control mice received water only. In 
studies of TNBS-colitis, mice were administered TNBS 3.5 mg (Sigma-Aldrich) delivered in 150µl 
of 50% ethanol per rectum as previously described (11). 
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Intestinal permeability studies 
Untreated mice or ML-7 treated mice were administered with a dose of 2mg/10g body weight of 
FITC-conjugated dextran dissolved in purified water (4000 mw, Sigma-Aldrich, Milan, Italy) per 
rectum. Whole blood was obtained via eye bleed one hour after FITC dextran administration. 
Blood samples were centrifuged at 3000 rpm to obtain sera; the latter was then analyzed by 
fluorometry using a Victor3™ (485/535nm, gain 1480) plate reader (Perkin-Elmer, Waltham, MA). 
Mice administered 50% ethanol per rectum were subsequently administered daily doses of  FITC-
conjugated dextran dissolved in purified water per rectum and whole blood was obtained via eye 
bleed one hour after FITC dextran administration. 
 
Adoptive transfer of LPMC 
LPMC were isolated from colons of Nod2+/+ and Nod2-/- ethanol-treated mice 1 day after ethanol 
administration. LPMC (4.0 x105) were then injected i.v. into the tail vein of Nod2+/+ and Nod2-/- 
mice, respectively. In some experiments, additional mice of each group were administered LPMC 
depleted of LAP+ T cells by cell sorting after staining cells with anti-mouse CD4-PerCP (RM4-5 
BD Pharmingen, S. José, CA ) and biotinylated goat anti-LAP (R&D Systems, Minneapolis, MN ) 
-streptavidin APC using a FACS-ARIA. TNBS 3.5 mg was administered per rectum to the 
recipient mice 5 days after the LPMC transfer as previously described (11). The occurrence and 
course of colitis in the different groups of animals was evaluated as described in the text.  
 
Histological assessment of colitis 
Tissues removed from mice at indicated times of death were fixed in 10% neutral buffered formalin 
solution (Sigma-Aldrich) and then embedded in paraffin, cut into tissue sections, and stained with 
H&E. Stained sections were examined for evidence of colitis by a pathologist (ISTOVET di Luca 
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Crippa & C. S.A.S., Besana in Brianza (MB), Italy) and scored using previously reported criteria 
(11)
 
 
Protein extraction 
Mouse colonic   specimens   were rinsed with cold PBS, blotted dry, and immediately frozen in 
liquid nitrogen for   protein extraction .Total protein extracts were prepared as previously described 
(35)
. Briefly, snap frozen mucosal samples were homogenized in buffer containing 10 mM Hepes 
(pH 7.9), 60 mM KCl, 1 mM EDTA, and 0.2% Nonidet, supplemented with 1 mM dithiothreitol 
(DTT), 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 1 mM phenylmethanesulphonyl fluoride, 1mM 
sodium orthovanadate, 1mM sodium fluoride (all reagents were from Sigma)  
 
Isolation and Culture of LP Mononuclear Cells (LPMC) 
LPMC were isolated from freshly obtained colonic specimens using a modification of the method 
described by van der Heijden and Stok (36). Isolated  LPMC were cultured at 1x106 cells /ml in 48-
well plates (Costar, Corning Incorporated life sciences, Tewksbury, MA ) coated or uncoated with 
murine anti-CD3e antibody (clone 145-2C11; BD Pharmingen) and containing X-Vivo medium ( 
Biowhittaker, Walkersville, MD)  supplemented with 1 µg/ml of soluble anti-CD28 antibody 
(clone 37.51; BD Pharmingen), as previously  described (11) . After 48 hours culture supernatants 
were harvested and stored at -80°C for future ELISA assay. 
 
In vitro Stimulation of  CD4+ LP  T Cells by CD11c+ LP DCs 
LPMC cells obtained from untreated mice were subjected to magnetic bead sorting using CD11c 
microbeads or a CD4+ T cell Isolation Kit II (Miltenyi Biotech, Auburn, CA) following the 
manufacturer’s instructions. The purity of LPMC CD11c+ and CD4+ cells were > 90 % and >95 
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%, respectively as assessed by immunofluorescence staining.  2x105 /ml of the CD4+ cells obtained 
from  Nod2-/- or  Nod2+/+  untreated mice were co-cultured with 1x105/ml CD11c+ cells obtained 
from   Nod2-/- or  Nod2+/+  untreated mice in the presence or in the absence of 500ng/ml 
Pam3CSK4 (InvivoGen, San Diego, CA).  At the end of 48 h culture, the cells were collected, 
washed and stained for LAP expression by flow cytometry. 
 
LPMC Immunofluorescence staining 
Freshly isolated and washed LPMC were subjected to Fc block with anti-CD16/CD32 (BD-
Pharmingen) and then stained with biotinylated goat anti-LAP (R&D Systems) or biotinylated 
normal goat IgG (R&D Systems). 
After 30’ incubation, cells were washed and incubated with streptavidin-APC. The cells were then 
incubated with PerCP-anti-mouse-CD3 (145-2C11, BD Pharmingen) and APC- Cy7 anti-mouse 
CD4 (GK1.5, BD Pharmingen), for an additional 30’. In some experiments, intracellular Foxp3 
expression was evaluated using APC-anti-mouse/rat Foxp3 staining set (eBioscience, San Diego, 
CA, USA ) following the manufacturer‘s protocol. The cells were then washed twice, and the 
percentage of fluorescent cells was quantified using a FACSAria (BD Biosciences) 
 
ELISA 
Cytokine concentrations in protein extracts and cell supernatants were determined by commercially 
available specific ELISA kits. IFN-γ: BD-OptEIA Set Mouse (BD Bioscience); IL-12p70: 
Quantikine ELISA (R&D Systems); IL-17: Quantikine ELISA (R&D Systems), IL-17: BD-OptEIA 
Set Mouse (BD Bioscience); mouse/rat/porcine/canine TGF-β1 quantikine (R&D systems) per the 
manufacturer’s recommendations).  
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Statistical analysis 
Assessment of statistical differences was determined by Student’s t test or by one-way analysis of 
variance (ANOVA) with Bonferroni’s multiple comparison test when appropriate. 
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Supplementary Material is linked to the online version of the paper at http://www.nature.com/mi 
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Figure Legends 
 
Figure 1. Nod2-/- mice exhibit increased colonic permeability and increased in vivo IL-12p70 
production, associated with an increased LP subpopulation of CD4+LAP+ T cells  and  enhanced 
in vivo TGF-β production. 
 A: measurement of colonic permeability by intrarectal administration of FITC- Dextran (see 
Methods). Data shown is derived from two  separate experiments, each involving five mice/group; 
data represent mean±SE; B and C: In vivo IL-12p70 and IFN-γ  production: cytokine content of 
protein extracted from lamina propria tissue was measured by ELISA; data  represent mean±SE 
derived from 12 mice in each group; D: LPMCs isolated from colonic tissue were cultured for 72 h 
in the absence of stimulation (US) or in the presence of anti-CD3/28 stimulation, after which the 
culture supernatants were assayed for IFN-γ content by ELISA; data represent mean±SE derived 
from 10 mice in each group. Data were tested for statistical significance using Student’s  t test. E: 
Percentage of LAP+ cells among CD3+CD4+ gated LP cells; data represent mean±SE derived 
from 12 mice/group; F: In vivo TGF-β production: TGF-β content of protein extracted from lamina 
propria tissue was measured by ELISA. Data represent mean±SE derived from 12 mice/group. 
Data were tested for statistical significance using Student’s   t test. 
 
Figure 2. Effect of ampicillin treatment (A) and  ML-7 treatment (B,C) on the fraction of  LP 
CD4+LAP+ cells among CD4+ LP cells.  
A. Separate groups of mice were treated with ampicillin 200µg/100µl distilled water   or 100µl 
distilled water alone (untreated) by oral gavage; for 14-21 days. Mice were sacrificed at 14 and 21 
days of Ampicillin treatment, and at 21 days of water treatment, respectively. LP cells from colons 
isolated, stained for CD3, CD4 and LAP and analyzed by flow cytometry. Each column represent 
mean±SE * =P<0.05. Nod2-/- mice untreated (distilled water only) vs Ampicillin-treated 21 days 
by Student’s t test. B. Separate groups of mice were treated for 4 days with ML-7 twice a day i.p 
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(see methods) . At the end of treatment mice were intrarectally administered FITC-Dextran (see 
methods). Columns represent mean±SE   of three mice/ group. C. Separate groups of mice were 
treated for 4 days with ML-7 twice a day i.p (see methods). At the end of treatment mice were 
sacrificed, colons were collected and isolated LP cells stained for CD3, CD4 and LAP and 
analyzed by flow cytometry.  Columns   represent mean±SE of data   from three different 
experiments. * P<0.05. Nod2-/- mice untreated vs ML-7 treated mice by Student’s t test. 
 
Figure 3. Induction of LP CD4+LAP+ cells by CD11c DCs in vitro.  
A. Percentages of LAP+ cells in purified lamina propria CD4+ T cell populations following co-
culture for 48 hrs. with CD11c+ DCs isolated from the lamina propria of Nod2-/-and Nod2+/+ 
mice. Column  represent mean±SE of data from two different experiments. B. Percentages of LAP+ 
cells in purified lamina propria CD4+ T cell populations following co-culture for 48 h. with 
CD11c+ DCs isolated from the lamina propria of Nod2-/- and Nod2+/+ mice in the presence or in 
the absence of  Pam3CSK4. Column  represent mean±SE of data from two different experiments. 
 
Figure 4. Nod2-/- mice exhibit increased permeability but decreased inflammation vs. Nod2+/+ 
mice upon intra-rectal ethanol administration. 
A. Colonic permeability in Nod2-/- and Nod2+/+ mice after administration of intra-rectal 50% 
ethanol measured by serum FITC-dextran uptake (See Methods); data represent mean ±SE derived 
from two different experiments in which three mice/group were evaluated *=P<0.05 day 1 vs 
untreated; B. Mouse body weight changes after intra-rectal ethanol administration; each point 
represents mean±SE of daily weights expressed as percentage of day 0 weight; data represent 
pooled values derived from three different experiments in which five mice/group was studied. * 
P<0.01 Nod2-/- vs. Nod2 +/+; C. Representative microscopic appearance of colons of mice 
administered ethanol and sacrificed at  the time-points shown ;  H&E staining 40x magnification. 
Nod2-/- and Nod2+/+ untreated and day 3:  normal colonic architecture/patterns. Nod2+/+ day2:  
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Presence of mild submucosal edema and mild inflammatory infiltration. Nod2-/- day 2: normal 
colonic architecture/pattern; D: In vivo IL-12p70 production after 50% ethanol administration. 
Each point represents mean± SE of pooled values derived from two experiments in which 5 
mice/group were evaluated at each time point; * P<0.05 Nod2+/+ day1 vs. untreated mice.  
**P<0.05 Nod2-/- vs. Nod2+/+ untreated mice. E: IFN-γ tissue content at different days after 
ethanol administration. Each point represents mean± SE as described in D;* P<0.05 Nod2+/+ day1 
vs. untreated. Data were tested for statistical significance using Student’s  t test. 
 
Figure 5. Effect of ethanol administration on CD4+LAP+ T cells  
A. Percentage of LAP+ T cells among CD3+CD4+ gated LP cells after ethanol administration. 
Each point represents mean± SE of pooled values derived from three experiments in which 5 
mice/group/ were evaluated; * P<0.05 Nod2-/- day 1 vs. untreated; * P<0.05 Nod2+/+ day 2 vs. 
untreated; ** P<0.05 Nod2-/- vs. Nod2+/+ untreated and day 1; B. In vivo TGF-β production after 
ethanol administration. Each point represents mean± SE as described in A. * P<0.05 day1-2 vs. 
untreated Nod2-/- mice; * P<0.05 day 1-2-3 vs. untreated Nod2+/+ mice; **P<0.05 untreated and 
day 1 Nod2-/- vs. Nod2+/+ mice. Data were tested for statistical significance using Student’s  t 
test. 
 
Figure 6. Nod2-/- mice exhibit less severe TNB-colitis compared with Nod2+/+ mice.  
Mice were administered intra-rectal ethanol/TNBS to induce TNBS-colitis or ethanol alone. A. 
Body weight changes; Each point represents mean ±SE weight at indicated times expressed as 
percentage of day 0 weight and derived from three different experiments in which  five mice/group 
were evaluated; * P<0.05 ethanol/TNBS-treated  Nod2-/- vs. Nod2+/+ ; B. histological appearance 
of representative colonic tissue of TNBS-treated mice sacrificed at day three after TNBS 
administration; H.&E. staining, 40x magnification: a, Nod2+/+: severe, diffuse ulcerative colitis 
with dense transmural inflammatory cell infiltration of the submucosa, the smooth muscle and the 
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serosa layers. b, Nod2-/- mild, non-ulcerative colitis with mild submucosal edema and mild 
inflammatory cell infiltration; Colitis score *P<0.05 ethanol/TNBS-treated  Nod2-/- vs. Nod2 +/+  
by Student’s  t test. C. and D. in vitro IFN-γ and IL-17 production by unstimulated and anti-
CD3/CD28-stimulated LPMC; data represent mean±SE of pooled values derived from three 
different experiments in  which five mice/group were evaluated . Data were tested for statistical 
significance using one way analysis of variance with Bonferroni’s multiple comparison test. 
 
Figure 7. Adoptive transfer of CD4+LAP+ T cells ameliorates severity of TNBS-colitis  
Mice were administered intra-rectal ethanol/TNBS to induce TNBS-colitis alone or TNBS-colitis 
in adoptively transferred LPMCs or LAP+ T cell-depleted LPMCs mice. A and B. Body weight 
changes; each point represents mean ±SE weight at indicated times expressed as percentage of day 
0 weight and derived from an experiment in which six mice/group were evaluated; * P<0.05  
TNBS-colitis in Nod2-/- recipients of LAP+ T cell-depleted LPMC vs. recipients of LPMC  and  
Nod2-/- mice with TNBS-colitis alone; C: histological appearance of representative colons of 
different groups of  Nod2-/- mice sacrificed at day 3 after TNBS administration; H&E staining, 40x 
magnification: a, mild submucosal edema with mild inflammatory cell infiltration; b, moderate 
ulcerative colitis with moderate submucosal edema and inflammatory cell infiltration; c, normal 
colonic architecture/patterns; Colitis score: * P<0.05 TNBS-colitis in Nod2-/- recipients of LAP-
depleted LPMC vs. recipients of LPMC  and  Nod2-/- mice with TNBS-colitis alone.  D. 
histological appearance of representative colons of different groups of Nod2+/+ mice sacrificed at 
day 3 after TNBS administration; H&E staining, 40x magnification: a, severe, diffuse, transmural 
ulcerative colitis with severe, submucosal inflammatory cell infiltration also involving the smooth 
muscle and serosa layers; b, marked ulcerative colitis with moderate submucosal edema and 
inflammatory cell infiltration; c, moderate ulcerative colitis with moderate submucosal edema and 
inflammatory cell infiltration. E-H: “in vitro” IFN-γ and IL-17 production by isolated LPMC. Data 
represent cumulative mean±SE from 6 mice /group. Data were tested for statistical significance 
using one way analysis of variance with Bonferroni’s multiple comparison test.  
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Figure 8.  Mice were administered intra-rectal ethanol/TNBS to induce TNBS-colitis in untreated 
Nod2+/+ mice or in Nod2+/+ mice adoptively transferred LPMCs or LAP- depleted LPMCs from 
ethanol-treated Nod2-/- mice. A: Body weight changes; each point represents mean ±SE weight at 
indicated times expressed as percentage of initial weight; these data were from 2 experiments with   
eight mice/group except for LAP-depleted LPMC recipient group in which 5 mice were evaluated; 
*P<0.05 TNBS-colitis in Nod2+/+ recipients of Nod2-/- LPMC vs. Nod2+/+ mice with TNBS-
colitis and Nod2+/+ mice recipient of LAP -depleted Nod2-/- LPMC   B: histological appearance 
of representative colons of different groups of mice sacrificed at day 3 after TNBS administration; 
H&E staining, 40x magnification: a, severe, diffuse, transmural ulcerative acute colitis with severe 
submucosal inflammatory infiltration deeply involving  the smooth muscle and serosa layers; b, 
moderate submucosal oedema and moderate inflammatory infiltration ; c, severe, diffuse, 
transmural ulcerative acute colitis with severe submucosal inflammatory infiltration deeply 
involving  the smooth muscle and serosa layers ;d, normal architecture/patterns with small 
lymphoid nodules. Colitis score: ;*P<0.05 TNBS-colitis in Nod2+/+ recipients of Nod2-/- LPMC 
vs. Nod2+/+ mice with TNBS-colitis and Nod2+/+ mice recipient of LAP-depleted Nod2-/- 
LPMC.  Data were tested for statistical significance using one way analysis of variance with 
Bonferroni’s multiple comparison test.  
 
Figure 9.  Nod2-/- mice   were either single-housed (n=5) or co-housed at a 1:1 ratio with Nod2+/+ 
mice  (n=5) on the same diet for a 4-week period. A: % of LP CD4+LAP+ cells in the single-
housed or co-housed mice. *P<0.05 by Student’s t test. B: Body weight changes; each point 
represents mean ±SE weight at indicated times expressed as percentage of day 0 weight. *P<0.05 
by Student’s t test. C: Histological appearance of representative colons of mice sacrificed at day 3 
after TNBS administration; H&E staining, 40x magnification. Colitis score: * P<0.05 by Student’s 
t test 
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Supplementary Figure 1. Mice were administered ethanol 50% intrarectally at day 0 and at day 4 
after the 1st administration. A: Body weight changes; each point represents mean ±SE weight at 
indicated times expressed as percentage of day 0 weight and derived from an experiment in which 
five mice/group were evaluated. B: % of LP LAP+ cells in CD3+CD4+ gated LPMC observed in 
mice sacrificed before and at day 4 after the 1st ethanol administration. Data represent values 
obtained from pooled LPMC isolated from 3 additional mice at day 0 and 4.  
 
Supplementary Figure 2. Representative dot plots of LPMC stained for LAP and Foxp3 (% in 
CD3+CD4+ gated LP cells) isolated from colons of Nod2-/- and Nod2+/+ mice treated or not with 
ethanol 50% i.r. 
 
Supplementary Figure 3. Mice received dextran sulfate sodium (M.W.36, 000-50,000) (DSS) 2% 
(w/v) in their drinking water for 7 days. A: Body weight changes; each point represents mean ±SE 
weight at indicated times expressed as percentage of initial weight and derived from an experiment 
in which five mice/group were evaluated. * P<0.05 Nod2-/- vs Nod2+/+ mice at indicated times 
after DSS administration by Student’s t test. B: Mice were sacrificed at day 12, colons were 
collected and myeloperoxidase activity (MPO) was evaluated. * P<0.05 Nod2-/- vs Nod2+/+ mice   
by Student’s t test. 
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4. CONCLUSIONS 
 
These studies show that an increase in intestinal permeability (both in a transitory and a chronic 
form) leads to an increase in the mucosal resistance to inflammation through the induction of 
regulatory T cells. Therefore, an increase in the intestinal permeability with a consequent increase in 
the exposure of the host to products of the intestinal microbiota could represent an important 
mechanism of induction and maintenance of the intestinal tolerance homeostasis. The observation 
that mice with a Nod2 gene deletion have an increase in the CD4 + LAP + regulatory cells, which 
determines a slighter damage following the induction of colitis, clearly shows that this genetic 
alteration by itself is not sufficient for the onset of Crohn’s disease. The greater regulatory response 
to the microflora associated with the Nod2 mutation could explain why the lack of Nod2 is not 
sufficient to establish inflammatory lesions in the experiment animal and to provide an 
interpretation for the established presence of an increased intestinal permeability in healthy relatives 
of patients suffering from Crohn’s disease, notwithstanding the presence of the same genetic 
polymorphisms. 
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